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ABSTRACT 
Copy number expansion of genetic content is a powerful way in which species 
adapt to environments, and a powerful mechanism by which novel genes are generated. 
DUF1220 domains were previously identified as showing the largest human lineage-
specific increase in copy number of any protein coding sequence with the human 
genome. While the function of DUF1220 domains remains obscure, the Sikela lab has 
identified a strong correlation between increasing DUF1220 copy number and increases 
in both brain size and cortical neuron number within great apes. In addition, a 
significant association has been reported between reduction and gain of DUF1220 copy 
number and brain size in microcephaly and macrocephaly, respectively . This thesis 
investigates the function of DUF1220 domains by further investigating the correlation 
between DUF1220 copy number and several physical brain measurements within 
anthropoid primates (monkey, ape and human). The spatiotemporal expression pattern 
in human fetal brain tissue was then evaluated, and suggested a role in neural 
progenitor expansion. In vitro cell culture experiments were then used to demonstrate 
the ability of DUF1220 to promote proliferation of human neural stem cells. 
Transcriptomics and proteomics studies both suggested a role in down regulating 
mitochondrial function, and this result was confirmed by live cell imaging using a 
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mitochondrial dye. Finally, a functional evaluation of mitochondrial output in DUF1220 
over expressing cells was performed, and found to slightly reduce metabolic output. I 
offer potential explanations linking the ability of DUF1220 to promote proliferation with 
the apparent reduction in mitochondrial output. 
 
The form and content of this abstract are approved. I recommend its publication. 
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Copy Number Variations 
The role of copy number variations in evolution. In mammalian prophase I of 
meiosis, the process of crossing over aligns homologous maternal and paternal 
chromosomes and reshuffles the genetic content between them, generating two hybrid 
chromosomes that each contain a unique sequence that neither parental chromosome 
contained before the process began.  This process is mediated, in part, by sequence 
alignment: homologous sequences are juxtaposed and used as cues for proper 
alignment.  The presence of multiple copies of a sequence can lead to inappropriate 
alignment, however, such that the resulting gametes contain duplicated or deleted 
Figure I.1: Mechanism of Copy Number Variations 
In the left scenario, maternal and paternal chromosomes line up 
appropriately, and crossing over occurs at positions indicated by red X’s. 
Each of the resulting gametes, below, have the same copy number of the 
sequences indicated by the red boxes. In the right scenario, the 
chromosomes are misaligned, such that rearrangement leads to one 
gamete with fewer copies of the sequence in question, and one gamete 
with more copies. Any genetic material in between these sequences will 




genetic content (Figure I.1). 
A non-lethal duplication of genetic content typically results in the elimination of 
the duplicated sequence, most likely because the resulting structural polymorphism can 
have adverse effects, such as disease or other general reduction in fitness.  Further, 
there may be little value in the redundant sequences that could offset the added 
metabolic drain required for producing extra, unnecessary copies of a gene product.  A 
subset of the duplicated content can become fixed in the genome, however, and is 
therefore a substrate for evolution.  As long as one copy of the gene remains functional, 
the other copies are under far less selective pressure, and can therefore accumulate 
mutations at a much more rapid rate (Figure I.2).  Subsequent mutations may simply 
produce pseudogenes and ultimately degrade the content altogether, but they can also 
alter the function and expression of the gene or a subset of domains within the gene.  
Mutations in a specific domain, for example (such as binding, regulatory, anchoring or 
catalytic domains), may affect the function of these domains (such as increased or 
decreased affinity for a target), or render them useless entirely. This internal duplication 
of genetic domains increasing gene size “is one of the most important steps in the 
evolution of complex genes from simple ones ( Graur and Li 2000, 255).” 
Alternatively, mutations in a regulatory region, such as the promoter, can change 
the spatiotemporal distribution of the gene product, or responsivity to transcription 
factors.  Mutations can also drive subfunctionalization in such a way that each of the 








Figure I.2: The Fate of Duplicated Genetic Content 
Most duplicated sequences are eliminated from the genome, but 
a fraction becomes fixed within a population. A fixed duplication can 
either be degraded or accumulate mutations that lead to either a novel 
function for the duplicated content (neofunctionalization) or a division of 
ancestral functions into two specialized genes (subfunctionalization). 
Subfunctionalization can affect the regulatory regions (as shown) such 
that each gene has a different expression, or can result in each gene 
containing a subset of the protein domains originally contained within 




between them and allowing evolution to manipulate even more specific traits without 
affecting other traits no longer linked to that trait.  This mechanism of evolution has 
therefore been a powerful force in the generation of functional genetic content, and 
indeed it is thought that all gene families have expanded in this manner (Hurles 2004). 
Although only a fraction of duplicated content actually becomes fixed in the 
genome, duplications are a very frequent event, so the effect is still quite substantial.  In 
fact, large scale genomic rearrangements are among the most common genetic 
phenomena observed in nature.  Itsara et al. estimate approximately 8-25kb of DNA are 
deleted or duplicated in each generation in humans, while only about 100 bp of point 
mutations are generated (Itsara, et al. 2010), and these are spread across 3 billion base 
pairs, only 2% of which encode proteins.  Large scale rearrangements resulting in copy 
number differences are therefore a very powerful force in driving evolutionary 
plasticity. 
The pattern of genomic recombination in mammalian genomes – that is, the 
specific genetic content that is affected – is not consistent across all species, however.  
Genomic recombination is non random, and appears to follow ancestral blocks of 
duplicated content, termed core duplicons (Marques-Bonet and Eichler 2009).  In the 
non-primate, mammalian species thus far investigated, including mouse, dog, rat and 
cow, nearly all large segmental duplications occur in a tandem organization on the same 
chromosome, while in primates there is a tendency for duplications across non-




separated by more than 1 Mbp of sequence from their nearest paralog (She, et al. 
2008). 
The rates of genomic recombination are also dynamic. Fortna, et al. 2004, 
Dumas, Kim, et al. 2007 and Hahn, Demuth and Han 2007 suggest a burst of duplication 
in the primate lineage, which is particularly interesting in light of the observation that 
other forms of mutations appear to have been slowing down in primates through this 
time period (Wu and Li 1985; Li and Tanimura 1987; Mouse Genome Sequencing 
Consortium; Waterston, RH; Lindblad-Toh, K; Birney, E 2002; Chimpanzee Sequencing 
and Analysis Consortium 2005).  These observations not only highlight the importance 
of genomic rearrangements in speciation, but also suggest an even stronger emphasis 
on duplications in the primate lineage, which appears to have taken an evolutionary 
path that diverges from the mammalian archetype. 
Copy number increases that lead to dosage increases are known to be able to 
accumulate with tremendous speed. Wild type peach-potato aphids, for example, were 
known to carry two esterases, E4 and FE4, which are able to hydrolyze and sequester 
organophosphorous insecticides. Following exposure to these selective agents, resistant 
strains of the aphids were found to carry multiple copies of both E4 and FE4. The gene 
duplication and subsequent increase in carrier frequency are thought to have occurred 
only within the last 60 years (Graur and Li 2000, 282). This example not only highlights 




species, but also hints that primates may also have experienced very powerful selective 
pressures that have prompted the primate specific burst in duplicated content. 
Array-based comparative genomic hybridization. Because lineage specific copy 
number variations (CNV’s) not only help identify regions of a genome that are currently 
evolving and help to distinguish species, but may also be an important, defining feature 
of our own species, Fortna et al. used microarray-based comparative genomic 
hybridization (array CGH) to identify primate CNV’s (Fortna, et al. 2004).  Array CGH is a 
technique wherein two different sources of DNA are labeled with different fluorescent 
colors and then co-hybridized to a reference in order to compare binding affinity.  
Hybridization is performed on a microarray chip, such that at any given locus, stronger 
representation of one color over another indicates an enrichment of the DNA bound to 
that color, and therefore greater copy number of that sequence (Figure I.3). 
Fortna et al. used human cDNA (derived from PCR-amplified IMAGE clones) as a 
reference spotted on a microarray.  Genomic DNA from several species was isolated and 
DpnII digested.  Human (n = 4) DNA was random primer labeled with Cy3-dCTP and 
designated “reference.”  Chimpanzee (n =4), gorilla (n = 3), orangutan (n = 3) or bonobo 
(n = 3) DNA was labeled with Cy5-dCTP and designated “test.”  Both test and reference 
samples were co-hybridized to the microarray chip.  The unbound DNA was then 
washed off of the chip, and the chip was imaged with a GenePix 4000B slide scanner for 




compared copy number for 39,711 non-redundant cDNA clones (representing 29,619 
human genes) for each species. 
 
 
Figure I.3: Array-Based CGH Setup 
A microarray chip was prepared, containing 39,711 nonredundant cDNA 
clones. Human genomic DNA was digested and randomly labeled with Cy3-dCTP 
(shown here as green strands). A test sample was also digested and randomly 
labeled with Cy5-dCTP (shown in red). These two labeled DNA samples were co-
hybridized to the microarray chip containing human DNA. Because the green 
sample consistently matched the arrayed cDNA’s in a 1:1 ratio, any change in 
copy number in the test sample would appear as an uneven ratio, such that 
additional copies would produce a stronger signal, and fewer copies would 
produce a weaker signal. In the example shown, the test sample has 3 copies of 
ErbB2, compared to only 1 in human. On the microarray chip, this locus 




This study identified 815 different genes that gave array CGH signatures unique 
to a specific hominoid lineage (Figure I.4).  Of these, the human lineage showed 134 
increases and 6 decreases in copy number.  Genes that have been lost in the human 
lineage completely would not be detected in this study, as human DNA was used to spot 
the microarray chip for comparison.  Approximately half of the 134 sequences that 
showed an increase were represented as expressed sequence tags (EST’s) or 
uncharacterized, with little or no annotation.  Of the remaining genes with functional 
annotation, many of those identified were implicated in neural function, which may help 
to explain why a majority of the syndromic and complex diseases associated with 
genomic regions that identified as combination hotspots involve neurocognitive and 
neurobehavioral diseases (Marques-Bonet and Eichler 2009).  Duplicated genes with 
neural-related functions included: 
a neurotransmitter transporter for GABA (SLC6A13), a leucine zipper-
containing gene highly expressed in brain (KIAAA0738), α7 cholinergic 
receptor/Fam7 fusion gene (CHRFAM7A), a p21-activated kinase (PAK2), 
a Rho GTPase-activating protein (SRGAP2), a Rho guanine nucleotide 
exchange factor (ARHGEF5) that is a member of the rhodopsin-like G 
protein-coupled receptor family, and Rho-dependent protein kinase 
(ROCK1). Inhibition of ROCK1 has been shown to prevent long-term 
memory, and ROCK1, together with a RhoGEF and RhoGAP, have been 
recently implicated in a model of long-term memory based on fear 
conditioning (Lamprecht, Farb and LeDoux 2002). Also, members of the 
ARHGEF, PAK, and RhoGAP gene families comprise a disproportionately 
high fraction of the genes known to produce syndromic or non-syndromic 







Figure I.4: Compilation of Primate Lineage Specific Copy Number 
Variations 
The colored bar at the top indicates the species in question (indicated by 
the key at the bottom right), and each column represents a different individual 
from within that species. Each row is a different locus within the genome. A 
green signal indicates a copy number loss in that species, while a red signal 
indicates a copy number gain in that species. Note the large block of duplications 




In summary, this study provided a wealth of information describing many of the 
characteristics that are specific to each of these primate lineages, and offered many 
clues as to how each of these species has evolved, suggesting evolutionary pressures 
each lineage may have faced (and may still be facing). The most highly duplicated 
protein coding sequence in the human genome did not have a known function, and was 
known only as Domain of Unknown Function 1220 (DUF1220) the PFAM database 
(pfam.sanger.ac.uk). 
DUF1220 domains. BLAT queries of the human genome indicate that humans 
have approximately 272 copies of DUF1220, and that these domains exist in one of two 
possible gene families. The first, PDE4DIP (Phosphodiesterase family member 4D 
Interacting Protein), is a large gene with several other domains, including an N-terminal 
microtubule associating domain and several coiled-coil domains along its length. Several 
transcripts of this gene exist in the literature (RefSeq lists 9 alternative transcripts). 
Transcript 1, the full length transcript, is a verified transcript expressed at the protein 
level, and contains one DUF1220 domain near its C-terminal end. This protein product 
was found to interact with PDE4D – a protein that hydrolyzes cAMP. It is expressed at 
the Golgi/centrosome region, where it’s thought to anchor PDE4D (Verde, Pahlke, et al. 
2001). PDE4DIP is expressed in many tissues, though is most strongly expressed in heart 
and skeletal muscle, with somewhat attenuated expression in brain. PDE4DIP is most 
likely playing a role in signaling cascades related to cAMP, possibly involving calcium 




Dependent Kinase 5 Receptor Associated Protein 2), is also a golgi/centrosomal protein 
with microtubule binding ability (Fong, et al. 2008) that has been linked to microcephaly 
(Bond, et al. 2005), although it lacks a DUF1220 domain. 
The second context in which DUF1220 domains are found is within a family of 
genes called NBPF (Neuroblastoma Break Point Family), named after the founding 
member, NBPF1, was discovered as having been disrupted in a neuroblastoma patient 
(Vandepoele, Van Roy, et al. 2005). In contrast to PDE4DIP, these genes rarely, if ever, 
have domains other than DUF1220 (Figure I.5).  With the exception of the occasional 
coiled-coil domain, DUF1220 domains are the only apparent protein domains in the 
family, existing in as many as 52 copies within one gene (according to the PFAM 
database of protein families, http://pfam.sanger.ac.uk/), and no NBPF gene exists 
without a DUF1220 domain. Little else is known about the NBPF family of genes. The 
BioGPS database of tissue expression (BioGPS.org) indicates that NBPF’s tend to be 
expressed in many tissues, and strongly expressed in the testis, immune system, and 
regions of the brain including the prefrontal cortex and nonspecific fetal brain. Work 
from our own lab has confirmed neural specific expression within the brain using an 
antibody of our own design (Popesco, et al. 2006). 
Sequence analysis of available genomes has revealed that DUF1220 domains do 
not exist outside of mammals, and exist in comparatively low copy number in non-
primate mammals (1 - 8 copies). Interestingly, DUF1220 copy number appears to have 




number rapidly climbs to double and ultimately triple digits with phyletic proximity to 
humans (O’Blenness et al., 2012). This primate specific burst in copy number may 
indicate an effect unique to primates. We therefore evaluated the relationship of 
Figure I.5: Graphical Depiction of DUF1220 Organization Within Genes 
Each row indicates a different gene, and red boxes indicate DUF1220 
domains. The top 5 rows are PDE4DIP genes, and the red box is the same size as 
those below it (indicating the relative size of the gene). In this genomic context, 
one solitary DUF1220 domain exists in the C-terminal half of the gene, and other 
domains (including an N-terminal microtubule binding domain, blue) exist within 
the gene. By contrast, the remaining lines indicate NBPF genes, in which 




DUF1220 copy number to both brain size and cortical neuron number estimates in 
primates (Figure I.6). Both cortical neuron number (R2 = 0.98; p = 0.0011) and brain size 
(R2 = 0.98; p = 1.8 x 10-6) comparisons show a very strong correlation to DUF1220 copy 
number. It is worth noting that Neanderthal brain size, inferred from cranial capacity, 
continues this trend with DUF1220 copy number, derived from whole genome 
sequencing (Dumas, et al. 2012). This is not true for any other gene in the 1q21.1 region, 
where most DUF1220 domains exist. 
Alignment of all human DUF1220 sequences suggests 7 distinct phylogenetic 
clades. The first, the PDE4DIP clade, is thought to be the ancestral form of the domain, 
as it is the most diverged and most broadly conserved clade. The remaining 6 clades can 
be subdivided into two groups. The first are called CON-type domains, because they are 
conserved through non-primate mammals. There are three of these, CON1, CON2 and 
CON3, which consistently occur in this order within NBPF genes. The remaining three 
are human lineage specific, or HLS-type clades. These, too, are numbered HLS1, HLS2 
and HLS3, and occur in this order. Although these domain types are found in other 
primate genomes and are therefore not truly human lineage specific, there has been a 
human specific amplification of these types of domains in particular. This amplification 
has specifically expanded the HLS “triplets” (HLS1+HLS2+HLS3 in tandem), rather than 
any one HLS type domain. The expansion of these triplets has occurred intragenically, 
such that homologous NBPF genes in the chimpanzee genome differ in their 




An alignment of 2,000 bp upstream of NBPF genes reveals a 900 bp sequence of 
high similarity, called the CM promoter (conserved among all mammals) (O'Bleness, et 
al. 2012). The transcription factor binding site database TRANSFAC detects two binding 
motifs. An OCT4 binding site, thought to be important in pluripotent stem cell 
embryogenesis (Wang and Dai 2010), and an IRF1 binding site, implicated in interferon 
induction, as well as tumor suppression, cell cycle control, an apoptosis ( Romeo, et al. 
2002). These transcription factor interaction predictions are consistent with observed 
expression in the developing brain and immune system in the BioGPS database. 
A second promoter was also detected by Vandepoele, Andries and van Roy 
(2009). This promoter appears to have been duplicated from an unrelated gene, EVI5, 
sometime after the simian/prosimian split, but before the simian radiation. This EVI5 
promoter is not found in all NBPF genes, and may offer an alternative start site for those 
in which it does exist. The EVI5 gene encodes a centrosomal protein that has a role in 
cell cycle progression, and is a potential oncogene (Lim and Tang 2013). Instances where 
an EVI5 promoter drives NBPF expression may therefore provide appropriate 







Figure I.6: Graphical Depiction of the Evolutionary 
Expansion of DUF1220 Domains 
Domain sequences were aligned and the relationship 
of DUF1220 domains to one another is indicated by relative 
wheel position. The “CON” domains are conserved through 
several mammalian species, while the "HLS” domains were 
named for their human lineage specific expansion. The 3 HLS 
clades are not found in most mammalian species, and are 
thought to be the result of CON3 duplications in higher 





Copy number of DUF1220 domains has also been linked to cognitive diseases, 
such as autism, schizophrenia, macrocephaly and microcephaly. Diseases like autism 
and schizophrenia have very high rates of incidence, occurring at around 1.1% (Centers 
for Disease Control and Prevention 2012; National Institutes of Mental Health), and 
although they seem to have a genetic component, no strong genetic element has so far 
been described. The genomic instability in the 1q21.1 region caused by a very high 
content of repetitive sequences may be at least partly to blame. Indeed, NBPF11 has 
been identified as one of 8 core duplicons driving genomic recombination in the human 
genome (Marques-Bonet and Eichler 2009). Segmental deletions that occur in the 
1q21.1 region, where most DUF1220 domains exist, have been linked to schizophrenia 
(Walsh, et al. 2008), and duplications have been linked to autism (Mefford, et al. 2008). 
Similarly, deletions in 1q21.1 have also been linked to microcephaly, while duplications 
have been linked to macrocephaly (Brunetti-Pierri, et al. 2008, Figure I.7). 
The heavy genetic burden caused by such high genomic instability in this region 
is therefore most likely offset by a tremendous advantage. In congruence with this 
notion, when evaluated for Ka/Ks ratios (a method that evaluates the ratio of 





Figure I.7: Summary of genomic copy number variations 
known to be associated with cognitive diseases. 
Gaps in the reference genome (black) are indicated, along with 
the positions of DUF1220 domains (yellow) and the NBPF genes in 
which they exist (green). Other genes not containing DUF1220 
domains are indicated below in gray. The relative positions of 
deletions (red) and duplications (blue) are shown beneath, and the 
reference from which the data was taken is indicated above each CNV. 
Deletions associated with microcephaly have been categorized into 
Class I (smaller) and Class II (larger). Figure from Dumas, et al. 2012. 
(Grozeva, et al. 2012; Stefansson, et al. 2008; International 




selection), DUF1220 sequences have signatures of very strong positive selection. A 
Ka/Ks ratio of 1 or greater is a generally accepted threshold indicating positive selection, 
and most DUF1220 sequences have values between 2 and 4, with some sequences 
having values as high as 7.25 (Popesco, et al. 2006). 
This dichotomy of a heavy genetic burden caused by a genomic instability that is 
evolutionarily maintained but is offset by an unknown advantage led us to propose a 
model (Figure I.8). This model proposes that genomic instability maintains evolutionary 
plasticity, making possible an evolutionarily rapid accumulation of DUF1220 domains, 
and the selective value of these domains offsets the burden of neurological diseases. 
This model is also consistent with the theory that autism and schizophrenia are 
diametrically opposed diseases (Crespi, Stead and Elliot 2010). 
Developmental Neuroscience in Primates 
Primate neocortical brain development. The primate brain is derived from a 
neural tube, an embryonic structure that is formed by the invagination of ectodermal 
tissue to form a groove that ultimately closes to form a discreet tube shaped structure 
running the axial length of the embryo. In humans, this process begins at around 16 




 development, the neural tube is comprised of a central canal (lumen), surrounded by a 
neuroepithelial layer of cells. The neuroepithelial cells in this layer form a 
pseudostratified layer, and are attached at both the lumen on the apical side, and to the 
outer limiting membrane on the basal side, by processes extending from the cell body. 
The nucleus of these cells is mobile along this apical-basal axis, and follows a predictable 
path during the cell cycle. During G1, they migrate away from the luminal surface, 
 
Figure I.8: Proposed Mechanism Linking 
DUF1220, Brain Evolution and Disease 
In this model, genomic instability drives 
frequent recombinations. These recombinations 
rapidly increase the number of DUF1220 in the 
genome, conferring some evolutionary advantage, 
possibly an increase in brain size. Because an 
evolutionary advantage is conferred by maintaining 
this genomic instability, the instability itself is 
selected for, and thus retained. In addition to gains in 
DUF1220, however, the instability can also lead to 
deleterious rearrangements, and these may underlie 
diseases such as microcephaly and schizophrenia, in 
the case of 1q21.1 deletions, and macrocephaly and 




toward the basal surface, followed by S phase at the basal surface. They then migrate 
back towards the luminal surface during G2, and undergo mitosis at the luminal surface. 
This mechanism of nuclear migration may conserve limited space at the luminal surface, 
suggesting that this surface is an important factor in proper cell division. At this stage of 
development, these cyclical movements toward and away from the lumen take about 
24 hours per cycle. Once cycling has completed, neuroepithelial cells differentiate into 
neuroblasts. Starting at about 35 days, some of the neuroblasts will break their 
attachments and migrate away from the lumen, forming new mantle and marginal 
layers, thus reducing the size of the neuroepithelial layer as cells leave it. These are the 
rudimentary layers from which the brain will be derived. 
This neural tube will eventually give rise to the brain and spinal cord, the anterior 
half of which is called the basal plate, and gives rise to efferent (motor) output from the 
brain to muscles and glands. The posterior half is called the alar plate, and is associated 
with afferent (sensory) input to the brain and spinal cord from peripheral regions.  In the 
spinal cord, these two regions are nearly equal. In the cranial third of the neural tube 
that will become the brain, however, the alar plate greatly expands, while the basal 
plate does not. Indeed, the cerebral hemispheres – representing 80 - 90% of the mass of 
the human brain – are entirely sensory in origin (Diamond, Scheibel and Elson 1985). 
By about three weeks post fertilization in a human, bulges along the length of 
the neural tube near the cranial end are apparent. They are the presumptive forebrain, 




at this point called a prosencephalon – divides through weeks 4 and 5 to produce the 
diencephalon and the telencephalon, the latter of which bifurcates along the midline to 
produce two lateral bulges that will ultimately become the cerebral hemispheres 
(Augustine 2008, 27). The telencephalon has three distinct zones, the archipallium 
(archi- “ancient,” pallium “covering” or “cloak”), which will give rise to the 
hippocampus; the paleopallium (“old”), which will give rise to the olfactory bulbs, and 
the neopallium (“newest”), which undergoes extraordinary growth and becomes the 
cerebral hemispheres. The neopallium begins expanding laterally between weeks 7 and 
8 and continues to expand through week 12. By this time, with the exception of the 
insular cortex (a small piece of cortex that does not expand laterally during this time, 
allowing the temporal lobe to extrude out from the rest of the brain), the neopallium 
has expanded so much that it has almost completely eclipsed the underlying 
paleopallium (Diamond, Scheibel and Elson 1985). 
The extensive lateral expansion of pallial tissue ultimately enables a broader gray 
matter component of the brain, the region occupied by cell bodies (as opposed to the 
white matter, which is primarily comprised of myelinated axons and some glial cells). 
This cortical expansion forces cortical folding, or gyrification, in order to fit the vast 
neocortex inside the cranium. Gyrification is driven by neuron number, and occurs in a 
lineage specific manner (Ventura-Antunes, Mota and Herculano-Houzel 2013). In 
humans, it is so extensive that 2/3 of mature cortical tissue is buried in the folds of the 




During this time, there are two sources of neurons in the developing brain. In the 
first, the radial glial cells (formerly the neuroepithelial cells in the neural tube) in the 
cortical ventricular zone (VZ) are organized in an epithelial sheet. They will produce glia, 
oligodendrocytes, and excitatory neurons radially out toward the pial surface, such that 
each radial glial cell produces a column of cells that arise from the same progenitor. In 
the second, the ganglionic eminence in the striatum produces inhibitory interneurons 
that migrate tangentially around the cortex to their appropriate locations (Martin 2003, 
74). 
The radial glia of the cortical VZ still have processes that contact both the 
ventricular and pial surfaces, and are the only cells known to do so. Radial glia are 
capable of self renewal divisions, and also have the potential to produce neurons, 
intermediate progenitor cells (which can divide to produce two neurons), and outer 
radial glia (oRG), which are similar to radial glia, but occupy a region further pial to the 
VZ called the outer subventricular zone (OSVZ), and whose processes only contact the 
pial surface, not the ventricular surface. oRG’s are similar to radial glial cells and are 
capable of producing intermediate progenitor cells (Lui, Hansen and Kriegstein 2011). 
As development proceeds, the developing neocortex begins to articulate into 





Figure I.9: Specification of transitory, developmental zones in the 
neocortex 
As development proceeds, cells occupying the ventricular zone give 
rise to daughter cells in waves. Each of these waves migrates basally 
through the IZ and past the previous wave and will ultimately become one 
of the adult neocortical layers. The cortical plate thickens as more post 
mitotic cells migrate into it, and the VZ and SVZ (not shown) both shrink as 
this happens. Times indicated are for mouse development. PS: pial surface. 
MZ: marginal zone. CP: cortical plate. SP: subplate. IZ: intermediate zone. 
VZ: ventricular zone. Reprinted by permission from Macmillan Publishers 





zone (ISVZ), the inner fiber zone, OSVZ, the intermediate zone, the cortical plate, the 
marginal zone and  the pial surface. The intermediate zone is the region through which 
differentiated neurons will migrate (using radial glial processes as guides), and the 
cortical plate is the region into which they will settle, ultimately forming the layered 
neocortex. The two subventricular zones are regions where further rounds of cell 
division occur. This organization of two distinct subventricular zones separated by a 
fiber layer seems to exist only in the primate. In mice, there is only one subventricular 
zone that is not subdivided (oRG’s and intermediate progenitors do still exist in the 
mouse) (Fahrbach 2013, 108-109). 
Gray matter expansion is particularly extensive in humans (Herculano-Houzel, 
Mota and Wong, et al. 2010). This expansion may arise by lateral divisions of neural 
stem cells in the VZ – the radial glia – as proposed by the Radial Unit Hypothesis (Rakic 
1991, Rakic 1988), or (based primarily on lineage tracing experiments in the rodent) by 
the lateral expansion of intermediate progenitor cells in the ISVZ, as has been proposed 
more recently (Lui, Hansen and Kriegstein 2011). 
During this period of broad expansion, radial glial cells occupy the VZ of the 
pallium and act as neural stem cells, giving rise to neurons, glia and oligodendrocytes 
(Figure I.11). Daughter neuronal cells produced by these cells are known to occupy the 
same vertical column in adults (Kornack and Rakic 1995), and so the Radial Unit 




 Figure I.10: The trajectory of cells within a radial unit 
expands the neocortex 
Radial glia occupying the VZ divide to produce 
daughter cells. Daughter cells born in this zone migrate 
basally (up), using the basal process of the cell that produced 
it as a guide, thus maintaining a columnar organization. The 
numbered RG at the bottom therefore corresponds to its own 
unique radial unit at the top. CC and TR connections project 
into the subcortical zones during this time. MZ: marginal 
zone. CP: cortical plate. SP: subplate. IZ: intermediate zone. 
VZ: ventricular zone. MN: migrating neuron. RG: radial glial 





produce more radial glia, before switching to divide asymmetrically, producing neurons. 
This hypothesis suggests that a symmetric division might yield equal distribution of fate 
determining factors, such as protein complexes that adhere the radial glial cells to the 
ventricular surface, and therefore maintain a neural stem cell identity. An asymmetric 
division, on the other hand, would yield one cell still adhered to the ventricular surface 
(and therefore still a neural stem cell) and a second cell no longer attached to the 
ventricular surface, free to migrate to the cortical plate and differentiate. Factors that 
control the differential mode of cell division between symmetric and asymmetric have 
been proposed to act on the mitotic centrosomes, as these may affect the orientation of 
the cellular division plane (Wang, Tsai, et al. 2009).  
As development progresses, there are fewer symmetric, self renewing divisions 
and more asymmetric, neurogenic divisions. Lateral expansion slows and the cortical 
plate (CP) thickens. The CP is a transient zone in the developing neocortex that is the 
target of migrating neurons, and will ultimately become the 6-layered adult neocortex. 
Radial glial daughter cells destined to become neurons in the neocortex are born in 
waves and migrate along the processes of radial glial cells. Once these cells reach the 
marginal zone (MZ; the most superficial layer), they stop migrating and begin to 
projecting neurites. In doing so, they migrate past any previous waves of neurons that 
have already settled in the CP, such that the developing neocortex is built in an “inside 




subsequent layer migrates past the previous layer, until the appropriate signal (most 
likely reelin) cues them to stop migrating (Vetter and Dorsky 2005, 130). 
Primate brain expansion: comparative brain mass. It is well accepted that the 
human brain is the seat of our species’ cognitive powers, but which features of our brain 
that can account for our unique behaviors has been a matter of debate. Defining which 
behaviors, if any, are unique to humans has itself been contentious. What was once a 
long list of supposedly unique features of human behavior has been continually reduced 
in recent years as neuroethologists discover more and more complex behaviors in other 
animals (see, for example de Waal and Tyack 2003). It may instead be true that there 
are few, if any, behaviors that are truly unique to humans, but that we instead elaborate 
tremendously our behaviors far beyond what any other observed animal is willing or 
able to do. This concept seems to imply that no unique features of the human brain 
have evolved, but instead that our brains have expanded the capabilities of those that 
already exist. While the debate about human behavior continues, however, research 
into the physical features of the human brain that are both unique to our species and 
similar to other species has made considerable progress in recent years. 
The human brain is neither the largest nor the smallest of all brains in nature, so 
size alone may not be enough to characterize our behavior. Instead, it has long been 
thought that the ratio of brain size to body size must instead account for our cognitive 
talents, since humans appear to stand out in this regard. This concept dates to Aristotle, 




( Aristotle). A simple brain to body size ratio expressed as a fraction therefore gives 
humans a value of 1/40 (Serendip Studio 2012). Mice, however, have the same value 
when calculated in this manner, and some of the smaller species of birds have an even 
more favorable ratio of 1/12, while animals like elephants have a very poor ratio of 
1/560, despite reports of remarkable intelligence (Hart, et al. 2001). 
A variation of this concept was proposed by Harry Jerison in 1973. Jersion 
plotted brain size against body size for several vertebrate species and used these 
empirical values to derive a power law (Jerison 1973). Rather than evaluating the brain 
to body size of an individual species in absolute terms and using this value for 
comparison, Jerison’s strategy takes into account allometric scaling between species. It 
is a relative measurement of an animal’s brain size to body size ratio as it compares to 
other species, making comparisons of animals of vastly different body sizes possible. The 
trend line observed by Jerison justifies the assumption that brain size correlates with 
body size, and in a way that can be described by a mathematical power function. Jersion 
used this trend line to describe an Encephalization Quotient (EQ) for several vertebrate 
species. An EQ value is a description of how far from this trend line each species 




mass1. A value less than 1 indicates a brain mass that is smaller than expected for a 
given body size (where expectations are derived from the trend line), a value greater 
than 1 indicates a larger than expected brain mass for a given body mass, and a value of 
1 indicates no deviation from the expected value. Using this system, mice have an EQ of 
0.5 and elephants have an EQ of 1.13-2.36 (Shoshani, Kupsky and Marchant 2006), while 
humans have an EQ of 7.4-7.8. Even when compared to primates alone, humans still 
have an EQ above 3 (Marino 1998). 
This study formally posits that our species therefore has a larger brain size than 
expected, given our relatively small body size. Initially, this idea seems to account for 
the fact that humans do not have the largest brains in nature, but appear to be the most 
behaviorally complex. A deeper investigation of this concept reveals some flaws, 
however. 
The EQ hypothesis implies that animals with smaller brains and larger EQ’s, such 
as capuchin monkeys, should outperform larger brained animals with smaller EQ’s, such 
as gorillas, in behavioral tests. This, however, is demonstrably false, as gorillas 
                                                     
1 Jerison did not actually fit a true regression line to his data. Instead, he inserted 
a line of slope 0.67 by eye. This was done because the relationship of surface to volume 
between two identical shapes of different sizes is 0.67, and Jerison suspected that this 
phenomenon would explain the allometric scaling of brain to body size, where the 
surface area is the surface area of the animal’s body. Subsequent analyses using a true 
regression line has found that the trend still holds, but that the actual slope is closer to 
0.75, which is also the power law that describes how basal metabolic rate scales as a 
function of body size. This has led to the proposal that the brain size to body size 




outperform capuchin monkeys in tests of cognitive performance (Deaner, et al. 2007). 
Brain structure, such as absolute brain mass and/or neuron number, may therefore be 
an important consideration. 
Finally, it is not immediately clear why the ratio of brain size to body size should 
affect cognitive performance much, if at all. Indeed, it is a counterintuitive notion that 
our small bodies are in fact what accounts for our cognitive abilities. It may be assumed 
that part of the brain must be dedicated to controlling the body, such that a larger body 
must therefore require a larger brain in order to control it. The brain to body size ratio 
would therefore describe the amount of brain “left over,” brain tissue that is not 
responsible for controlling the body which can therefore be used for other cognitive 
tasks. Evidence against this hypothesis comes in the form of fossilized remains of very 
large animals like members of the sauropodomorpha clade, which suggests a body size 
at least as big as 20,000 kilograms, and possibly even larger. While the estimates of 
brain size for these animals vary, they never exceed 0.5 kilograms, giving the 
sauropodomorpha an EQ of substantially less than 0.2, and meaning that very little 
neural tissue may be required for body control (Hopson 1980). 
Though intriguing, the observed phenomenon that brain mass and body mass 
tend to trend together in many species may actually be circumstantial, and any attempt 
to assign causality (and therefore infer information processing abilities) should be 
undertaken with great caution. Such studies are thoughtful investigations of human 




same number of neurons per unit of volume, such that a larger brain must have more 
neurons and an increased capacity for information processing. This assumption is 
understandable given the lack of empirical data available at the time of the studies, but 
more recent investigations of mammalian brain architecture have revealed this to be a 
misconception. 
Comparative Neuron Number 
Herculano-Houzel and Lent devised a novel method of counting the number of 
neuronal and non-neuronal cells in brain tissue samples, called Isotropic Fractionation    
( Herculano-Houzel and Lent 2005). Their method can use fixed or frozen brain tissue 
from the desired brain region within the desired species. Tissue samples are ground into 
a buffer using a tissue homogenizer such that the cellular plasmalemma is lysed but 
nuclei are preserved. A sample of nuclei is then diluted into a working range and then 
immunoreacted for NeuN, a nuclear protein that is thought to be specific to neurons 
(both mature and immature). After immunoreactions, nuclei are DAPI labeled and 
counted under a fluorescence microscope, and a ratio of NeuN positive cells (number of 
neuronal nuclei) to DAPI positive cells (total nuclei) is obtained. 
This technique was applied to the brains of several rodents (Herculano-Houzel, 
Mota and Lent 2006), primates (Herculano-Houzel, Collins, et al. 2007; Herculano-
Houzel and Kaas 2011), and insectivores (Sarko, et al. 2009), from which the scaling 
rules of neuronal size and density across species were devised. Two very important 




the cerebral cortex across all species investigated is not indicative of the number of 
neurons contained within it, and second, that the cellular scaling and distribution laws 
are not constant across all species, but instead vary by lineage (Herculano-Houzel 2009). 
This new data indicates that although a human’s brain may seem impressive 
when size or EQ is compared to other mammals, it is in fact not an outlier within the 
primate lineage in any metric, but instead has the approximate architecture one would 
expect for a generic primate brain the size of a human’s. 
More specifically, neuron number trends much more closely with overall brain 
mass within primates than within rodents, and neuron number trends with cortical mass 
much more closely in primates (cortical mass (M) ∝ neuron number (N)1.077) than it does 
in either rodents (M∝N1.744) or insectivores (M∝N1.520). This indicates that as brain mass 
increases within the rodent lineage, so does cell mass. In primates on the other hand, 
cell mass changes very little. A larger primate brain therefore means greater gains in 
neuron number (Figure I.11). This is reflected in the scaling densities, which do not scale 
with brain size in primates, but decrease in rodents with increasing brain size. In the 
words of Suzana Herculano-Houzel: “the larger the brain size, the larger is the difference 
in number of neurons across similar-sized rodent and primate brains” (Herculano-
Houzel 2009). Although the lineages explored thus far include only primates, 
insectivores and rodents, this trend may explain the behavioral differences between 
humans and other large brained animals, such as elephants, dolphins and whales, where 





These differences in scaling rules highlight the inadequacies of morphometric 
comparisons across different mammalian lineages. Such comparisons may mask actual 
Figure I.11: Graphical Description of the Neuronal Scaling 
Rules Within the Cerebral Cortex of the Primate and Rodent Lineages 
Rodent (blue) and primate (red) are plotted over arbitrary 
values to indicate the relationship between brain mass and neuron 
number within each lineage. There is little difference in neuron 
number at low brain mass, but as brain mass becomes larger, the 
difference in the number of neurons between a rodent and a primate 
become greater. In these regions of larger brain mass, a larger rodent 
brain experiences fewer and fewer gains in total neuron number. 
Because increases in primate brain mass appear to be explained 
almost exclusively by gains in neuron number, a larger brain indicates 
larger numbers of neurons. Data from Herculano-Houzel 2009. Plot 




biological trends, and may therefore be uninformative or even misleading. Comparisons 
within lineages, on the other hand, may reveal important lineage specific characteristics. 
Comparisons of brain mass within the primate lineage might help inform our 
understanding of the cognitive capacities of primate species, for example, as brain mass 
is accounted for almost exclusively by neuron number within this lineage. When 
evaluated in the context of primate neuronal scaling rules, a large human brain is now 





SCOPE OF THE PROJECT 
The goal of this project was to elucidate any of the biological functions of 
DUF1220 domains. Because DUF1220 domains show a strong correlation with overall 
brain size and cortical neuron number in primates, in addition to associations with 
several human cognitive diseases, it was hypothesized that they may play a role in brain 
development, particularly in the expansion of neural progenitors. The association with 
neuron number suggested a potential role in controlling the cell cycle of primate neural 
progenitor cells during neocortical development. 
In lieu of cost prohibitive primate research, this hypothesis was to be 
investigated in post mortem human fetal brain tissue and human cells in culture. The 
primary methods of investigation were in situ hybridization of human tissue, live cell 
imaging analysis of actively cycling cells, and high throughput mRNA sequencing of cells 







The observation that brains do not scale uniformly across all species has 
elucidated many features of mammalian brain architecture. In addition to invalidating 
comparisons of brain to body size ratios across lineages, it has revealed that anthropoid 
primates in particular have taken a unique path in neuronal scaling. Because other 
lineages all tend to scale up neuron size with brain size but primates don’t, it is 
suggestive that these two features are connected in all other lineages and passively 
controlled by a size mechanism (possibly metabolic in nature), while cell size and density 
is actively being controlled independently of brain size in anthropoid primates. 
This mechanism seems to make brain architecture more efficient in keeping cells 
no larger than necessary for function, such that an anthropoid brain can have many 
more neurons than a non-anthropoid brain of similar size, implying that an anthropoid 
primate brain may be doing more with the same amount of energy. 
This trend in neuronal scaling, coupled with the observation that DUF1220 copy 
number expansion is also limited to anthropoid primates, raises the possibility of a role 
for DUF1220 beyond simply driving neural expansion. Instead (or in addition), DUF1220 
may be responsible for this neuronal scaling, possibly by diverting metabolic energy 
away from growth and towards division. Rather than simply suggesting exaggerated or 




energy demands, a model of metabolic efficiency that drives neuronal proliferation at 
the expense of cell size is sensitive to the constraints of limited resources imposed on 
animals. Rather than suggesting unlimited growth, a natural boundary is imposed upon 
neuronal expansion based on available resources, which are known to be important not 
only for development, but critical factors in evolution. In this way, a model of DUF1220 
driving neuronal scaling primarily, which is secondarily driving neuronal expansion, 
tethers an animal to its environment, considers energy demands during development, 
and provides a much more direct explanation of the intense selective pressures on 
DUF1220: limited resources. A role in driving metabolic efficiency is also consistent with 
the recent finding that primates use far less energy than expected for a placental 
mammal of similar size (Pontzer, et al. 2014). These findings suggest novel avenues for 
possible investigation of DUF1220 function. 
DUF1220 Domains Are Associated with Increased Neural Stem Cell Proliferation in 
Simian Primates and Drive Proliferation in Human Neurons 
Introduction. Comparison of DUF1220 copy number among >40 mammalian 
species indicates that DUF1220 has undergone a major copy number expansion 
specifically among the anthropoid suborder of primates (monkeys, apes and humans). 
Among anthropoids, the most striking increase is found in humans, where DUF1220 
shows the greatest evolutionary copy number expansion of any protein coding 
sequence in the human genome (>270 copies in human; 160 of which are unique to 




O'Bleness, Dickens, et al. 2012, Dumas and Sikela 2009). This burst in copy number 
shows a close correlation with both brain size and neuron number specifically among 
primates and thus fits well with the recent proposal that primate brain expansion has 
proceeded via a unique evolutionary path of neuronal scaling ( Dumas, O'Bleness, et al. 
2012, S. Herculano-Houzel 2009). 
The majority of DUF1220 copies map to 1q21 and DUF1220 copy number loss 
and gain have been implicated in 1q21.1-associated microcephaly and macrocephaly, 
respectively ( Brunetti-Pierri, et al. 2008, Mefford, et al. 2008). DUF1220 copy number 
was also shown to be significantly associated with brain gray matter volume in a non-
disease population ( Dumas, O'Bleness, et al. 2012). Lastly, we have recently shown that 
increases in dosage of the CON1 DUF1220 clade exhibit a linear correlation with 
increased severity of each of the three primary symptoms associated with autism, a 
disease linked to brain overgrowth (manuscript submitted). Given these findings that 
link DUF1220 dosage to human brain expansion, two independent but complementary 
approaches in an effort to gain new insight into the function of DUF1220 domains 
during human brain development. 
Materials and methods: human fetal brain tissue samples. Fetal tissue samples 
were collected from spontaneous abortions from 2009 to 2013, formalin fixed and 
paraffin embedded for archival at the University of Colorado Hospital.  Samples with no 
abnormal brain related diagnosis were screened for intact cortical/neural tube tissue.  




Materials and methods: LNA probes for in situ hybridization. Two non-
overlapping oligo sequences (A and B) for human NBPF were identified 5’-
ATCCAGCAGCTCCCTGCTGA-3’ and 5’-TCTTGCAAGACTTCAGGCCCTT-3’. Locked nucleic 
acids (LNA™) were designed into the sequence resulting in RNA Tm’s of 84oC for both 
probes. We also included a scramble LNA probe and a miR-126 LNA probe (See 
Jørgensen methods). The LNA oligos were 6-carboxyfluorescein (FAM)-labeled at the 5’- 
and 3’-ends (double-FAM labeled probes) and obtained from Exiqon, Vedbæk, Denmark. 
Materials and methods: in situ hybridization. In situ hybridization was performed 
using a Tecan in situ hybridization instrument (Tecan, Männedorf, Switzerland) 
essentially as described elsewhere [10]. In brief, 6-μm thick tissue sections were pre-
digested with proteinase-K (25µg/ml for 8 minutes at 37oC). In situ hybridization was 
performed by incubating the two double-FAM labeled NBPF LNA probes mixed or 
separately at 40 or 60 nM diluted in Exiqon hybridization buffer at 57oC for 1 hour. 
Double-FAM labeled scramble (60 nM) and miR-126 (at 60 nM) probes were used as 
negative and positive controls, respectively.  After stringent washes in SSC buffers, the 
sections were incubated with alkaline phosphatase–conjugated anti-FAM (1:800, Roche, 
Mannheim, Germany). Slides were developed in 4-nitro-blue tetrazolium (NBT) and 5-
brom-4-chloro-3’-Indolyl-phosphate (BCIP) substrate (Roche) for 60 minutes resulting in 
a dark-blue precipitate. Slides were counter stained with nuclear fast red (Vector 




Materials and methods: image processing. Pairs of images (DUF1220 probe and 
Scramble probe) were obtained at identical exposures on a Nikon i80, and adjusted for 
levels by the same values between pairs in ImageJ. Each image was split into component 
color channels, red, green and blue, and the green channel was discarded. A 
representative measurement window large enough to span several cells, but not 
including damaged tissue or the ventricular surface (because of edge artifacts), was 
defined and applied to all four images in the same manner via the ROI Manager. In the 
event that the measurement window had to be moved in order to avoid the ventricular 
surface or damaged tissue in one image, it was done so identically for both channels. 
Mean gray values were then measured and recorded, and the gray value images were 
then rotated and scaled as necessary for presentation in figure 2. Blue channel values 
are primarily Nuclear Fast Red, and were thus used to control for non-specific staining 
differences, while the red channel primarily measures in situ probe (BCIP) signal. In situ 
values were therefore defined as red channel difference minus blue channel difference 
for each pair of images (Figure III.1). A negative value thus indicates a stronger probe 
signal in the Scramble sample than in the test sample. 
Materials and methods: live cell imaging. H9 derived human embryonic stem 
cells (Gibco #N7800-100) were plated at approximately 60-70% coverage in a six well 
plate (Falcon #353046) pre coated with CellSTART CTS (Gibco #10142-01) and cultured 
at 37 degrees with 5% CO2 in complete media (KnockOut DMEM/F-12 (Gibco #12660-





Recombinant FGF-Basic (Gibco #PHG0024),  2µg per 100 mL of Recombinant EGF 
(Gibco #PHG0314) and 0.2% serum (Gibco #A10508-01)).  After 24 hours, cells were 
switched to minimal media (KnockOut DMEM/F-12 supplemented with 1% GlutaMAX -I 
and 0.2% serum) and transfected with a synthetic NBPF15 construct (OriGene 
Figure III.1: Probe Quantification 
Tissue samples reacted with DUF1220 probe (A and C) or 
Scramble probe (B and D) were split into component channels to isolate 
probe signal (BCIP; red channel, A and B) from Nuclear Fast Red (blue 
channel, C and D). Gray values were quantified in the area indicated by 
the red box, which was applied identically to all four images. Blue channel 
differences were used to normalize staining variation between samples, 
such that probe values were defined as red channel differences minus 
blue channel differences. A negative value therefore indicates stronger 






#RC212377 ) or a mock construct (OriGene #PS100001), using TurboFectin 8.0 (OriGene 
#TF81001) according to manufacturer’s specifications.  Briefly, 3µL of TurboFectin 8.0 
per well was added to 100 µL of Opti-MEM I Reduced Serum Medium (Gibco #31985-
070) per well, gently mixed by pipetting, and incubated at room temperature for 5 
minutes.  Plasmid DNA was then added (1µg per well), gently mixed by pipetting, and 
incubated at room temperature for 30 minutes.  Transfection mixture was then added 
to each well drop-wise.  Images were collected in a 4 x 4 array in an Incucyte ZOOM 
(Essen Bioscience) once every 4 hours.  Incucyte software was trained to identify cell 
coverage on an image of the cells.  Raw numbers from this processing definition were 
plotted and a first degree polynomial curve was fitted to them with R in order to define 
the growth period in the NBPF15-transfected cells. Original images used to plot cell 
coverage were also manually inspected for morphological differences that might 
confound the coverage metric, such as actively apoptotic cells or floating cells no longer 
adhered (Figure III.2), and no such differences were detected. 
Results. First, in an effort to determine whether expression of DUF1220 is 
localized to brain regions undergoing neural stem cell expansion, in situ hybridization 
was used to investigate DUF1220 expression in human fetal brain tissue samples 
collected from spontaneous and induced abortions spanning virtually the entirety of 
human fetal brain development (gestational weeks (G.W.) 6 - 39).  Analysis of these 






at the RNA level predominantly in the ventricular and subventricular zones, the primary 
sites for production of new excitatory neurons (Figure III.3 – Figure III.5). This expression 
overlaps with the cortical neurogenic window, though not earlier or later. 
While no signal was detected at week 6 or 7 (Figure III.6), expression was detected in 
the G.W.  11.5 and 12 samples, during which the ventricular zone is largest  (Figure III.3), 
where the strongest signal is present predominantly in the dorso-lateral ventricular 
zone.  A much fainter signal is detected at week 15, and no real signal is detected after 
this point.   
 
Figure III.2: Manual Inspection of Cell Coverage 
Comparison of cell coverage between mock (left) and NBPF15 
(right) transfected cells. While regional variations in cell density occurred 
between conditions, cells transfected with NBPF15 had generally more 
cells, indicating that measured differences in cell coverage were not due to 







Figure III.3: In situ hybridization results of human fetal brain tissues throughout 






Figure III.3: In situ hybridization results of human fetal brain 
tissues throughout development, part I: Stages 6 - 15 
The red color channel was extracted and compared in the region 
indicated by red rectangles after normalizing to blue channel differences 
(see Methods). Strong differences can be seen at G.W. 11.5 and 12, but 
not at other stages. Gray values were measured in ImageJ and 







Figure III.4: In situ hybridization results of human fetal brain 
tissues throughout development, Part II: Stages 16 - 25 







Figure III.5: In situ hybridization results of human fetal brain tissues throughout 
development, Part III: Stages 28 - 39 













Figure III.6: Timeline of DUF1220 Expression and Human 
Fetal Brain Development 
A: Timecourse of DUF1220 RNA expression. In situ 
hybridization values were plotted by gestational age, showing peak 
expression at gestational weeks 11 and 12. B: A timeline of human 
fetal brain development indicating general developmental events, 
including DUF1220 expression.  Strong DUF1220 expression is seen 
by 11.5 gestational weeks, tapers off to lower expression by week 15, 
and is gone by week 18, indicating strong expression by at least mid-
neurogenesis.  In addition to this timing, strong DUF1220 probe 
signal in the ventricular zone also suggests a possible effect on 
neurogenesis.  After Bayer, et al. 1993, Howdeshell 2002, and Tau 




Transient transfections of human neural stem cells in culture were then used to 
test the ability of DUF1220 domains to influence proliferation in vitro. Compared to a 
mock transfection (as NBPF genes are comprised almost exclusively of DUF1220 
domains, an empty vector was used), transfection of H9-derived neural stem cells with a 
DUF1220-encoding gene (NBPF15 cDNA) showed a greater rate of increase in cell 
coverage that lasts approximately 90 hours (Figure III.7).  More specifically, NPBF15-
transfected cells show an immediate increase in coverage within the first day, and 
continue to grow approximately 10%, while mock transfected cells begin to decrease 
within the first day, and increase only 3-4% over the duration of the proliferative burst. 
Discussion. Taken together, the studies presented here provide the strongest 
evidence to date that DUF1220 domains have influenced simian brain expansion via 
increased neural progenitor proliferation.  The appropriate spatiotemporal pattern of 
DUF1220 expression in the ventricular zone primarily during corticogenesis (Figure III.3, 
III.4, and III.5) and the ability of DUF1220 to drive neural proliferation in vitro (Figure 
III.7) are both consistent with DUF1220 domains playing a role in stimulating neural 





 Recent evidence has suggested that primate brain expansion is primarily due to 
unique scaling of neuronal constituents ( Herculano-Houzel 2009).  Specifically, gains in 
brain mass in the primate species are associated with far greater increases in neuron 
number than are found in other lineages. Consistent with this, the evolutionary 
expansion of DUF1220 copy number is confined to the simian suborder of primates and 
closely parallels increases in neuron number among these species ( O'Bleness, et al. 
2012; Dumas, et al. 2012).  Indeed, the work presented here provides additional support 
to the view that human evolutionary brain expansion is primarily a neuron number-
driven phenomenon, and points to increases in DUF1220 domain dosage as a key driver 
Figure III.7: Exogenous Expression of DUF1220 promotes Neural 
Progenitor Cell Number 
H9-derived human embryonic stem cells transfected with NBPF15 
(6 DUF1220 domains; circles) or an empty mock construct (triangles).  
Shown are three experiments comparing NBPF15 and mock constructs in 
which cells were cultured in a live cell imager (IncucyteZOOM) and 





behind this process. 
These data suggest that DUF1220 domains are expressed at the right time and 
place to influence neural stem cell proliferation in humans, and are associated with 
exaggerated neural stem cell proliferation in anthropoid primates.  In order to test the 
hypothesis that DUF1220 domains can promote neural stem cell proliferation, a 
construct bearing 6 DUF1220 domains was exogenously expressed in human neural 
stem cells, which showed an immediate burst of proliferation, compared to little or no 
change in a mock transfection.  Primate brain MRI results and ventricular zone 
expression data suggest a possible DUF1220-driven brain expansion via the horizontal 
growth of the cortex, though the mechanism by which this occurs is not known. 
Although expression of DUF1220 at the ventricular zone is consistent with expansion of 
neural stem cells, and therefore consistent with hypotheses such as the radial unit 
hypothesis ( Rakic 1995), expression in the sub-ventricular zone is also consistent with a 
mechanism of intermediate progenitor expansion ( Noctor, Martínez-Cerdeño and 
Kriegstein 2007). Though more work will be required to investigate possible mechanisms 
of cellular expansion in order to determine the relevance of DUF1220 to either or both 
of these possibilities, the work presented here, when taken together, provide the 
strongest evidence to date that DUF1220 domains have influenced anthropoid brain 






DUF1220 Domain Expression Down Regulates Mitochondrial Pathways 
Introduction. DUF1220 protein domains show a major increase in copy number 
in monkeys, apes and especially humans, where they have undergone the single 
greatest human-specific increase in copy number of any protein coding sequence in the 
genome ( Fortna, et al. 2004; Popesco, et al. 2006). DUF1220 domains are encoded 
almost exclusively by the NBPF gene family, and can be divided into 6 clades, CON1-3 
and HLS1-3. Previously, we have shown that copy number of DUF1220 is strongly 
associated with both total brain size and estimated numbers of cortical neurons in the 
primate lineage. Within the human lineage, we also described an association between 
DUF1220 copy number gain and loss and macrocephaly and microcephaly, respectively ( 
Brunetti-Pierri, et al. 2008, Mefford, et al. 2008). In addition to showing an association 
of DUF1220 dosage with increased neurogenesis in the primate lineage, we have also 
shown that these domains can stimulate proliferation in human neural stem cells in 
vitro (Keeney et al., submitted). Here, we use transcriptomics and proteomics to 
investigate pathways in which DUF1220 domains may be functioning. Using a colon 
cancer cell line with low endogenous DUF1220 expression (DLD1Tr21), we evaluated the 
effects of artificial over expression of NBPF1, a gene with 7 DUF1220 domains. The 
results link DUF1220 over expression to a substantial down regulation of mitochondrial 
pathways not present in a mock cell line, findings which were corroborated by live cell 
imaging experiments. Interestingly, when the cells are evaluated for changes in 




modest decrease in cellular metabolism. These findings are discussed in light of their 
potential relevance to 1) recently described primate-specific scaling rules regarding the 
size and number of brain neurons within the primate order, and 2) the extended 
window of neurogenesis that is found during primate brain development. 
Materials and methods: cell culture and live cell imaging. Doxycyclin 
hydrochloride (“dox;” Sigma, Bornem, Belgium) was used at a final concentration of 2 
μg/ml to induce expression of either NBPF1-IRES-EGFP or EGFP in DLD1Tr21/NBPF1 and 
DLD1Tr21/Mock cells, respectively. DLD1Tr21/Mock and DLD1Tr21/NBPF1 cells were 
described previously Vandepoele, Andries and Van Roy, et al. 2008. DLD1 cells stably 
transfected with a TET-ON vector bearing either a FLAG-NBPF1-IRES-EGFP (DLD1-NBPF1) 
or FLAG-IRES-EGFP (DLD1-MOCK) described in Vandepoele et al. (2008) were cultured in 
RPMI medium at 37 degrees in 5% CO2.  The colon cancer cell line DLD1Tr21 Tet-On was 
obtained from van de Wetering, et al. 2002. This Tet-On system activates transcription 
of the gene of interest in the presence of doxycycline (Dox). The cells were cultured in 
RPMI with 10% fetal calf serum, 100 U/ml penicillin and 100 μg/ml streptomycin. The 
cDNA for NBPF1-IRES-GFP, fused to an amino-terminal flag tag, was cloned in the 
pcDNA4/TO vector (Invitrogen). This construct was stably transfected in DLD1Tr21 cells 
using Lipofectamine reagent (Invitrogen) according to the manufacturer's instructions. 
Fluorescence activated cell sorting allowed rapid isolation of NBPF1-positive cells, and 
further subcloning of this population yielded a clone that was more than 90% positive 




for 48 h. As the transfected vector encodes a flag-tagged NBPF1 fusion protein, single 
colonies were tested for induction of NBPF1 expression by immunofluorescence staining 
with the anti-flag antibody (Sigma). 24 hours after plating, media was removed and 
replaced with media including 200nM MitoTracker (Gibco) and either 2 µg/mL 
doxycycline or no doxycycline.  Cells were then cultured at 37 degrees in 5% CO2 in an 
Incucyte (Essen Bioscience).  Red (MitoTracker), Green (IRES-EGFP indicating successful 
doxycycline induction) and phase contrast images were then collected every 4 hours. 
Materials and methods: RNAseq.  8 T-175 flasks (Falcon) each of 
DLD1Tr21/NBPF1 and DLD1Tr21/Mock cells were cultured at 37 degrees in 5% CO2.  
After 24 hours, media was changed.  Four flasks of each cell line were refreshed with 
medium containing doxycycline, whereas the medium of the other four flasks were 
refreshed with medium only.  After 24 hours, these cells were trypsinized (Gibco) and 
collected in complete medium.  Total RNA was harvested using RNEasy (Qiagen).  
mRNA’s were then selected for using oligo dT beads per the manufacturer’s instructions, 
reverse transcribed to cDNA and sequenced as described in the manufacturer’s protocol 
for Illumina HiSeq2000. 
Materials and methods: library preparation and Illumina sequencing. Libraries 
were constructed using 1 μg total RNA following Illumina TruSeq RNA Sample 
Preparation v2 Guide and the cDNA library was validated on the Agilent 2100 
Bioanalyzer using DNA-1000 chip. Cluster generation was done on the Illumina cBot 




Kit). Sequencing of the clustered flow cell was performed on the Illumina HiSeq 2000 
using TruSeq SBS v3 reagents. The sequencer was programmed with a single read at 100 
cycles. Sequencing images were generated through the sequencing platform (Illumina 
HiSeq, 2000). The raw data were analyzed in four steps: image analysis, base calling, 
sequence alignment, and variant analysis and counting. An additional step was required 
to convert the base call files (.bcl) into *_qseq.txt files. For multiplexed lanes/samples, a 
de-multiplexing step is performed before the alignment step. 
Materials and methods: RNAseq analysis.  On average, we obtained 20 million 
(range = 12 – 30 million) single-end 100 bp sequencing reads per sample. Reads were 
mapped against the human genome using Tophat (version 2.0.9) ( Trapnell, Pachter and 
Salzberg 2009) and the NCBI reference annotation (build 37.2) as a guide. We allowed 3 
mismatches for the initial alignment and 2 mismatches per segment with 25bp 
segments. On average, 90% (85 – 94%) of the reads aligned to the human genome. Next, 
we employed Cufflinks (version 2.1.1) ( Trapnell, Williams, et al. 2010) to assemble the 
transcripts using the RefSeq annotation as the guide, but allowing for novel isoform 
discovery in each sample. Isoforms were ignored if the number of supporting reads was 
less than 30 and if the isoform fraction was less than 10% for the gene. The data were 
fragment bias corrected, multi-read corrected, and normalized by the total number of 
reads. The transcript assemblies for each sample were merged using Cuffmerge. We 
next computed the transcripts' FPKM values by rerunning Cufflinks using the merged 




multiple transcripts that represent the same gene. All other analyses were performed in 
R/Bioconductor (R version 3.0.1). 
Significant genes were identified using the R package LIMMA Wettenhall and 
Smyth 2004. Significant genes were identified using the lmFit, eBayes, and decideTests 
functions (FDR < 0.05 and fold change > 1.5). The statistics were moderated using 
empirical Bayes shrinkage (via the eBayes function), global multiple testing strategy, and 
Benjamini & Hochberg adjustment. Gene set enrichment analysis (GSEA) was conducted 
using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) 
geneset definitions obtained from the Molecular Signatures Database v.3.1 (34). 
Enriched pathways were identified by running GSEA using 1000 permutations as a 
stand-along java app (version 2.0.13). 
Materials and methods: measurement of oxygen consumption rate (OCR). 
Oxygen consumption rates were determined using a Seahorse XF24 analyzer (Seahorse 
Biosciences, North Billerica, MA, USA) as previously reported by Lopert et al. (Lopert, 
Day and Patel 2012). Briefly, cells were plated at 30,000 cells/well and incubated 
overnight. After 24 hours, media was changed into fresh media with or without 
doxycycline. After 18 hours, cells were analyzed on a Seahorse XF24 analyzer. Different 
parameters of respiration were calculated by subtracting the average respiration rates 
before and after the addition of the electron transport inhibitors [0.1uM Oligomycin, 
0.3uM cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) and 0.3uM Antimycin-A]. 




antimycin-A post injection respiration), ATP turnover (baseline respiration minus 
oligomycin post injection respiration), H+ leak (oligomycin-respiration minus antimycin-
A post injection respiration), maximal respiratory capacity (FCCP stimulated respiration 
minus antimycin-A post injection respiration) and reserve respiratory capacity (FCCP 
stimulated respiration minus baseline respiration).   
Materials and methods: statistical methods. Data were analyzed in GraphPad 
Prism software version 5 (San Diego, CA, USA).  One-way ANOVA was used to between 
groups with a Newman-Keuls post-test.  Data are represented as mean ± SEM. 
Results: RNAseq. Gene set enrichment analysis of down regulated genes 
identified an abundance of pathways related to mitochondrial function, wherein all but 
one of the pathways identified are related to metabolic function (Table III.1).  These 
pathways are not found to be changed in the mock cell line (Table III.2), and those 
patterns that are found have much higher false discovery rates (values ranging from 
0.13 - 1.00, see Figure III.).  No clearly discernible pattern was evident in the list of up 
regulated pathways found in either cell line (Table III.3 and Table III.4), and false  
discovery rates were much higher (Figure III.). This may suggest that the events that 







Pathway Size NES FDR q-val 
1 MITOCHONDRIAL_INNER_MEMBRANE 54 2.60 0.000 
2 MITOCHONDRIAL_MEMBRANE_PART 46 2.57 0.000 
3 MITOCHONDRION 245 2.47 0.000 
4 ORGANELLE_INNER_MEMBRANE 60 2.46 0.000 
5 MITOCHONDRIAL_MEMBRANE 69 2.46 0.000 
6 MITOCHONDRIAL_ENVELOPE 75 2.45 0.000 
7 MITOCHONDRIAL_PART 94 2.35 0.000 
8 PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_C
OMPLEX 
14 2.06 0.007 
9 MITOCHONDRIAL_RESPIRATORY_CHAIN 22 2.00 0.012 
10 RESPIRATORY_CHAIN_COMPLEX_I 13 1.99 0.013 
11 NADH_DEHYDROGENASE_COMPLEX 13 1.98 0.015 
12 MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I 13 1.96 0.017 
13 FATTY_ACID_METABOLIC_PROCESS 31 1.94 0.019 
14 MITOCHONDRION_ORGANIZATION_AND_BIOGENESI
S 
36 1.93 0.020 
15 MONOCARBOXYLIC_ACID_METABOLIC_PROCESS 41 1.93 0.019 
16 PROTEASOME_COMPLEX 23 1.90 0.026 
17 COENZYME_METABOLIC_PROCESS 29 1.88 0.032 
18 OXIDOREDUCTASE_ACTIVITY 170 1.85 0.040 
19 OXIDOREDUCTASE_ACTIVITY_GO_0016616 34 1.81 0.058 
20 HYDROGEN_ION_TRANSMEMBRANE_TRANSPORTER
_ACTIVITY 
20 1.80 0.062 
 
Table III.1: Pathways associated with genes down regulated in 
our RNAseq analysis after exogenous expression of NBPF1 in 
DLD1Tr/NBPF1 cells 
Pathways detected here show similar or overlapping function 
(related to mitochondrial function), and tend to have very low false 






Pathway Size NES FDR q-val 
1 CYTOKINE_AND_CHEMOKINE_MEDIATED_SIGNALING
_PATHWAY 
10 1.91 0.259 
2 WOUND_HEALING 17 1.90 0.152 
3 NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION 11 1.86 0.167 
4 REGULATION_OF_CELL_DIFFERENTIATION 24 1.86 0.134 
5 ANATOMICAL_STRUCTURE_MORPHOGENESIS 146 1.82 0.189 
6 ANATOMICAL_STRUCTURE_FORMATION 24 1.81 0.173 
7 ANGIOGENESIS 20 1.79 0.189 
8 RESPONSE_TO_WOUNDING 52 1.78 0.172 
9 MULTI_ORGANISM_PROCESS 45 1.78 0.164 
10 CYTOKINE_ACTIVITY 33 1.77 0.162 
11 RESPONSE_TO_EXTERNAL_STIMULUS 87 1.76 0.157 
12 ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY 16 1.72 0.220 
13 NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION 18 1.72 0.216 
14 REGULATION_OF_MITOSIS 31 1.72 0.204 
15 REGULATION_OF_ANGIOGENESIS 11 1.71 0.207 
16 POSITIVE_REGULATION_OF_CELL_CYCLE 11 1.71 0.200 
17 VASCULATURE_DEVELOPMENT 25 1.71 0.188 
18 RAS_GTPASE_ACTIVATOR_ACTIVITY 15 1.69 0.202 
19 G_PROTEIN_COUPLED_RECEPTOR_BINDING 11 1.69 0.205 
20 RECEPTOR_BINDING 131 1.67 0.222 
Table III.2: Pathways associated with genes down regulated in 
our RNAseq analysis after exogenous expression of NBPF1 in 
DLD1Tr/Mock cells 
As with both tables of up regulated pathways (Table III.3 and 
Table III.4), mitochondrial pathways are not detected, and false discovery 
rates for detected pathways are generally much higher than those found 
in the NBPF1 cell line. There is also less agreement between pathways, 
which generates less confidence in the pathways that were discovered. 
Table generated by David Astling. 
Results of the RNAseq are generally in agreement with a proteomic study run by 





Pathway Size NES FDR q-val 
1 RAS_GTPASE_ACTIVATOR_ACTIVITY 15 -2.28 0.004 
2 PHOSPHOTRANSFERASE_ACTIVITY_ALCOHOL_GROUP_AS
_ACCEPTOR 
208 -2.16 0.018 
3 CELL_CORTEX 25 -2.13 0.025 
4 ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PAT
HWAY 
69 -2.09 0.032 
5 CORTICAL_CYTOSKELETON 11 -2.09 0.026 
6 PROTEIN_KINASE_ACTIVITY 175 -2.09 0.022 
7 PROTEIN_AMINO_ACID_PHOSPHORYLATION 157 -2.05 0.032 
8 TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KIN
ASE_ACTIVITY 
18 -2.04 0.029 
9 GTPASE_ACTIVATOR_ACTIVITY 29 -2.03 0.029 
10 CELL_CORTEX_PART 15 -2.01 0.035 
11 SMALL_GTPASE_REGULATOR_ACTIVITY 38 -2.00 0.037 
12 PROTEIN_AMINO_ACID_AUTOPHOSPHORYLATION 18 -1.99 0.038 
13 ADENYL_RIBONUCLEOTIDE_BINDING 103 -1.98 0.040 
14 PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 134 -1.98 0.039 
15 ATP_BINDING 98 -1.98 0.037 
16 KINASE_ACTIVITY 229 -1.98 0.035 
17 TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KIN
ASE_SIGNALING_PATHWAY 
41 -1.95 0.044 
18 PROTEIN_AUTOPROCESSING 19 -1.95 0.042 
19 PROTEIN_TYROSINE_KINASE_ACTIVITY 33 -1.95 0.040 
20 ADENYL_NUCLEOTIDE_BINDING 107 -1.93 0.043 
Table III.3: Pathways associated with genes up regulated in our 
RNAseq analysis after exogenous expression of NBPF1 in DLD1Tr/NBPF1 
cells 
Much less agreement is observed between pathways. Table 
generated by David Astling. 
in culture in the presence of 13C6-Lys/Arg amino acid precursors (“heavy”), while DLD1-





Pathway Size NES 
FDR q-
val 
1 ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT 17 -1.73 1.000 
2 NUCLEAR_MATRIX 11 -1.71 1.000 
3 INDUCTION_OF_APOPTOSIS_BY_INTRACELLULAR_SIG
NALS 
18 -1.69 1.000 
4 PHOSPHOINOSITIDE_BIOSYNTHETIC_PROCESS 21 -1.67 1.000 
5 CATION_BINDING 100 -1.66 0.923 
6 PROTEIN_OLIGOMERIZATION 23 -1.63 0.986 
7 TRANSITION_METAL_ION_BINDING 62 -1.62 0.900 
8 RNA_SPLICINGVIA_TRANSESTERIFICATION_REACTION
S 
22 -1.61 0.836 
9 RNA_SPLICING 66 -1.61 0.752 
10 HYDRO_LYASE_ACTIVITY 14 -1.59 0.754 
11 DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION_R
ESULTING_IN_INDUCTION_OF_APOPTOSIS 
11 -1.59 0.701 
12 PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_CO
MPLEX 
14 -1.59 0.645 
13 GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS 24 -1.59 0.597 
14 LYASE_ACTIVITY 35 -1.59 0.558 
15 RNA_POLYMERASE_ACTIVITY 15 -1.58 0.553 
16 PROTEASE_INHIBITOR_ACTIVITY 13 -1.57 0.563 
17 PROTEIN_HOMOOLIGOMERIZATION 15 -1.57 0.546 
18 MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS 35 -1.57 0.517 
19 CARBON_OXYGEN_LYASE_ACTIVITY 18 -1.56 0.506 
20 NUCLEAR_DNA_DIRECTED_RNA_POLYMERASE_COMP
LEX 
14 -1.56 0.482 
Table III.4: Pathways associated with genes up regulated in our 
RNAseq analysis after exogenous expression of NBPF1 in DLD1Tr/Mock 
cells 
Little agreement between pathways, and very high false discovery 
rates. Table generated by David Astling. 
 (“light”). Mass spectroscopy evaluation of heavy vs. light peptides revealed eight genes 




 NDUFS2, NDUFS8, NDUFS1 and UQCRB), all of which are related to mitochondrial 
function. 
Results: live cell imaging. Red fluorescence measured in vivo in both 
DLD1Tr21/NBPF1 and DLD1Tr21/Mock cell lines stained with MitoTracker CMSROX 
indicates strong down regulation of genes that are related to mitochondrial function, as 
 
Figure III.8: Histogram of False Discovery Rates 
False discovery rates from  
Table III.1 (light green), Table III.2 (light blue), Table 
III.3 (dark green), and Table III.4 (dark blue) are plotted as 
histograms. A standard threshold of 0.05 is indicated above 
the plot, revealing that most results from the DLD1-NBPF1 
experiment met this criteria, while results from the DLD1-




suggested by RNAseq and proteomic data.  Because the MitoTracker reagent binds 
directly to the mitochondrial membrane based on the proton gradient, this may indicate 
either fewer mitochondria or an attenuated proton gradient (though it may be possible 
that there are simply fewer available binding positions on the mitochondrial membrane 
due to protein content or 3 dimensional folding of the mitochondria).  Three metrics 
found to be strongly different are red object confluence (total amount of area covered 
by red signal), average intensity (strength of red signal), and red object area (size of 
individual red objects) (Figure III.). Red object confluence starts near 67% in all wells and 
shows at least a gradual decrease in all wells, but only in the NBPF1 over expressing well 
does it show an immediate and permanent drop to near zero, while no other well 
approaches zero. For average intensity, most wells peak near 24 hours around 30,000 
relative units, while the the NBPF1 over expressing cells stay near zero. Similarly, the 
average size of red objects rises to near 2,000 µm2 (of contiguous red signal, which may 
represent multiple mitochondria from multiple cells at its peak) by approximately 24 
hours in control wells, but this spike is severely attenuated in NBPF1 over expressing 
cells and immediately drops to near zero in NBPF1 over expressing cells. Interestingly, 
when the threshold of detection is set to only detect very bright signals that may be 
indicative of dividing cells, there is no change between wells.  
Results: seahorse. Functional analysis of mitochondrial output detected small 
but significant changes in output. Specifically, cells evaluated for baseline, maximum 






Figure III.9: Induction of NBPF1 over expression decreases 
visible mitochondria 
DLD1-NBPF1 or DLD1-MOCK cells with or without doxycycline 
were incubated with MitoTracker, a reagent which binds to 
mitochondria and fluoresces red. Coverage of red signal in the field of 
view, average intensity of red signal, and area of red objects are plotted 
against time over the course of three days from the time of doxycycline 
application, in each cell line with and without doxycycline to initiate 
transcription of the transgene. All three are all substantially reduced in 
the NBPF1 cell line when treated with doxycycline. Example red 
channel images are shown in the bottom row for comparison. Each 




 (a difference of 148.2 pmol/min in DLD1Tr21/NBPF1 cells after doxycycline treatment 
compared to a 124.9 pmol/min change in DLD1Tr21/Mock cells) and resting basal 
output (185.3 pmol/min difference in DLD1Tr21/NBPF1 cells compared to 128.4 
pmol/min difference in DLD1Tr21/Mock cells) (Figure III.10), although a small trend in 
this direction is also seen in the mock line.  H+ leak is also reduced in DLD1-NBPF1 cells 
treated with doxycycline (37.6 pmol/min/protein (µg/mL) difference in 
DLD1Tr21/NBPF1 cells compared to 3.7 pmol/min/protein (µg/mL) difference in 
DLD1Tr21/Mock cells), possibly indicative of the functional change underlying the 
reduction in MitoTracker signal, though this change is not significant. There is also a 
large difference in respiratory capacity (295.1 pmol/min/protein (µg/mL) change in 
DLD1Tr21/NBPF1 cells compared to 286.7 pmol/min/protein (µg/mL) change in 
DLD1Tr21/Mock cells), though the difference observed in the mock line is also 
significant (see Table III.5 for raw values used to calculate these differences).  
Discussion. Here we have used a series of experimental approaches to 
investigate the effects of in vitro over expression of the NBPF1 gene, which encodes 7 
DUF1220 protein domains. These results suggest that over expression of DUF1220 
domains leads to a decrease in visible mitochondria, though whether this result is due to 
a reduction in total mitochondria or a reduction in the proton gradient is unclear.  






Figure III.10: Mitochondrial output measurements showing a 
change upon the addition of NBPF1 
Figure III.A: A small but significant decrease in ATP turnover is 
observed in NBPF1 over expressing cells that is not seen in mock treated 
cells, indicating less energy is being used by NBPF1 treated cells. Figure 
III.B: The baseline, or resting energy usage in NBPF1 treated cells is 
significantly reduced, while the reduction in mock treated cells Is not 
significant. Figure III.C: Though not statistically significant, a suggestive 
decrease in proton leak is also observed in NBPF1 treated cells that is not 
observed in mock cells. Figure III.D: A significant drop in respiratory 
capacity was observed in mock cells, though the drop in NBPF1 over 





Table III.5: Raw values generated by the Seahorse 
XF24 
Raw values used to generate Figure III.. Values from 
between 4 and 6 replicates are displayed for each test 
indicated. + and - indicate with and without doxycycline, 




unexpectedly modest, given the striking decrease in MitoTracker signal. The 
mitochondrial down regulation could indicate a DUF1220-mediated shift in cellular 
energetics toward a more efficient mode. Such a shift to a more restrictive energy 
availability may contribute to the primate tendency to maintain neurons at a constant, 
relatively small size, rather than scaling up neuron size with increasing brain and body 
mass, as occurs in many other mammals. Consistent with this, the strong down 
regulation of mitochondria observed in NBPF1 treated cells is not observed when cells 
are plated at lower density (Figure III., Figure III. and Figure III.), indicating a possible 
mechanism of maintaining cellular density at a constant level. Larger neurons, such as 
those that occur in large bodied rodents, may require more energy to maintain 
compared to the smaller sized neurons found in primate brains. Indeed, the 
maintenance of a relatively constant neuron size has been shown to be a hallmark of 
primate brains and is a phenomenon generally absent among non-primate mammalian 
brains. DUF1220 copy number parallels this trend, with primate brain expansion being 
primarily the result of increasing neuron number while keeping neuron size constant. 
Further, the down regulation of mitochondria seen in Figure III. is not observed in cells 
plated at lower density (Figure III., Figure III. and Figure III.), suggesting this effect may 
be limited by a specific cell density threshold. This would be consistent with a model of 
primate brain evolution in which neuronal density is held constant throughout the 
primate order. This might explain the ability of DUF1220 to drive neural stem cell 




proliferation, but restricts proliferation at higher densities. This would catalyze early, 
ventricular zone expansion in a developing brain, but prevent overgrowth and maintain   
 
Figure III.11: Apparent mitochondrial coverage is affected by cell 
density 
DLD1Tr21/NBPF1 (columns 1 and 2) and DLD1Tr21/Mock (3 and 
4) cells were grown in the presence of MitoTracker as in Figure III.. 
Columns 1 and 3 were treated with doxycycline while columns 2 and 4 
were not. Cells were plated at high, medium and low density. The total 
amount of red signal coverage in the field of view is plotted as a 
percentage at four hour time points over three days. The pronounced 






a constant density wherever it is expressed. In this way, DUF1220 containing proteins 
might appear to be either tumor suppressors or oncogenic, depending upon whether   
Figure III.12: Apparent mitochondrial signal intensity is affected 
by cell density 
DLD1Tr21/NBPF1 (columns 1 and 2) and DLD1Tr21/Mock (3 and 
4) cells were grown in the presence of MitoTracker (red signal) as in 
Figure III.. Columns 1 and 3 were treated with doxycycline while columns 
2 and 4 were not. Cells were plated at high (row A), medium (B) and low 
(C) density. The intensity of red signal detected is plotted at four hour 
time points over three days. The pronounced drop in red signal seen at 






proper contact inhibition cues are intact. A cell density related mechanism may also 
explain why one sample in our RNAseq analysis showed a very strong effect while the 
Figure III.13: Apparent size of individual mitochondria is affected 
by cell density 
DLD1Tr21/NBPF1 (columns 1 and 2) and DLD1Tr21/Mock (3 and 
4) cells were grown in the presence of MitoTracker as in Figure III.. 
Columns 1 and 3 were treated with doxycycline while columns 2 and 4 
were not. Cells were plated at high, medium and low density. The size of 
individual red puncta in µm2 is plotted at four hour time points over three 
days. The pronounced drop in red signal seen at high cell density is not 




other samples induced to over express NBPF1 showed a considerably weaker effect 
(Figure III.14). This sample (sample “NBPF1_B”) may have reached a cell density high 
enough to trigger the down regulation of mitochondria, while the other NBPF1 samples 
(“NBPF1_A,” “NBPF1_B,” and “NBPF1_C”) had not yet reached that threshold. The 
MitoTracker experiments indicate that the over expression of NBPF1 is necessary to 
elicit this effect at high cell densities. 
Such a mechanism is consistent with the Warburg Effect – the observation that 
proliferative cells (whether embryonic or cancerous) have high rates of glycolysis 
instead of high rates of mitochondrial oxidative phosphorylation (as is seen in normal, 
non-dividing cells), despite the presence of high levels of oxygen ( Warburg 1956). 
Though it is unknown why this association exists, it is plausible that a down regulation of 
mitochondrial output, caused by DUF1220 expression, prevents cells from growing any 
larger, and instead promotes proliferation. Because neural stem cells are known to have 
high rates of aerobic glycolysis, while the more differentiated neural progenitors have 
lower rates of aerobic glycolysis ( Shyh-Chang, Daley and Cantley 2013), it is 
alternatively possible that the switch from mitochondrial oxidative phosphorylation 
itself is the cue to maintain cell division or begin differentiation. 
An additional possibility is that this reduction in energy available to cells may be 
related to neoteny, a specific form of heterochrony caused by a delay in the timing of 
two developmental events. Neoteny can therefore appear as the prolonged retention of 












Figure III.14: Heat Map of 
RNAseq Results 
Significant changes were 
found with the genes listed on the 
right. Samples are listed at the 
bottom, and replicates are 
arbitrarily labeled A-D. Blue 
indicates a down regulation of the 
gene listed in that row, and red 
indicates an up regulation. The 
intensity of the color indicates the 
strength of the change. Note that 
the association with these genes 
(which are driving the pathway 
associations reported in  
Table III.1) among the four 
“NBPF1” replicates is almost 
exclusively driven by sample 





development can substantially change the size and shape of an organ or organism. More 
specifically, it is thought to be capable of greatly increasing the size of structures, 
including the brain ( Gould 1977)). In this model, reduction in available energy may have 
resulted in a developmental slowdown such that the neurogenic window among 
primates was expanded over a greater time interval, allowing for production of greater 
numbers of neurons. This prolongation of neural development is thought to have 
increased as one moves from rodent (mouse) to primates, and among primates from 
monkey (macaque) to human (Kornack and Rakic 1998), patterns that are mirrored by 
DUF1220 copy number. In addition to extending the window of progenitor proliferation, 
this extended developmental window could give neurons enough time to migrate to 
their appropriate location in the cortical plate and send out processes before being 
surpassed by the next wave of post mitotic neurons, and thus provide enough time for 
primate brains to generate many more neurons without sacrificing neural structure. If 
true, and given the fact that DUF1220 is expressed in many but not all tissues, this might 
help to explain why some, but not all, features of human development appear to be 
neotenous when compared to other primates (Popesco, et al. 2006). 
A Mouse Model of DUF1220 in vivo 
Introduction. Because of the profound expansion in copy number that has 
occurred in anthropoid primates, humans and non-human primates are preferred 
research subjects for investigating DUF1220 function. These studies are essentially 




to in vitro, cell based systems. Though these latter systems are very powerful, they are 
limited in their recapitulation of a developing human neocortex, where I suspect 
DUF1220 exerts its function. In order to compliment the investigations of DUF1220 
function in human cell culture, I have also developed a mouse in which 6 copies of 
human DUF1220 have been transgenically inserted into the genome. Here I describe the 
generation of these mice and their initial characterization. 
Materials and methods. The CTD-2576B15 BAC containing NBPF15 was obtained 
from Open Biosystems as a glycerol stock. This stock was cultured overnight at 37 
degrees Celsius in the presence of 12.5 µg/mL chloramphenicol. DNA was purified from 
cultures using a BAC purification kit (Qiagen). Purified DNA was checked for predicted 
size on a pulsed field gel and checked for predicted banding patterns after digestion 
with EcoRI or BamHI. 
1 µg of purified, verified DNA was sent to Jackson Laboratories for pronuclear 
injection into a minimum of 150 C57BL/6J mouse eggs. Microinjected eggs were 
implanted into pseudo pregnant females according to standard Jackson Labs protocols, 
and the offspring were genotyped using primers AGAAGCCACAGTCCTTCAGC (Forward 
primer) and CAGGTCAGTTGTCCTGCTCA (Reverse primer). A total of 33 offspring were 
successfully generated, and 2 of these (both females) had genotypes consistent with a 
BAC integration were considered founders. 1 of these founders was very unhealthy and 





Genotyping is carried out using Forward primer GGAAGTGGAAGAGCCTGAAGTC, 
Reverse primer TGAGTCAGGTTGTTCAAAGTACATTG, and probe /56-
FAM/ACAGGACTCACTGGATAGATGTTATTCGACTCCG/3BHQ_1/. These are compared to 
signal obtained from an endogenous mouse sequence, using Forward primer 
CACGTGGGCTCCAGCATT, Reverse primer TCACCAGTCATTTCTGCCTTTG and probe 
/5HEX/CCAATGGTCGGGCACTGCTCAA/3BHQ_1/, which is used as a single copy 
reference. 
The BAC integration site was mapped using nested integrated PCR as described 
in Wang, et al. 2011. The first end of the BAC mapped to an intergenic region of mouse 
chromosome 3qA3. The second end has not yet been successfully sequenced.  The 













Results. At the time of development, regulatory regions associated with NBPF 
genes were unknown. Human bacterial artificial chromosomes (BAC’s) were therefore 
screened for those that encompassed a full NBPF gene and as much flanking material as 
possible, but no other genes. CTD-2576B15 was selected based on this criteria as the 
sequence to be inserted into the mouse genome. This BAC contains the gene NBPF15, 
which contains 6 DUF1220 domains and was the gene used in the human cell culture 
experiment previously described (Figure III.). It is currently known that NBPF genes are 
associated with two promoters, the CM promoter (Conservation among all Mammalian 
NBPF genes) and the EVI5 promoter (O'Bleness, et al. 2012), which appears to have 
been duplicated from the unrelated gene, EVI5 ( Vandepoele, Andries and van Roy 
2009). CTD-2576B15 contains one of each of these promoters. 
This DNA was used introduced into the mouse genome by pronuclear injection at 
Jackson Labs, and integrated randomly at very low probability. One viable mouse was 
generated in this manner and was used to start a successful colony bearing one 
linearized copy of CTD-2576B15. Using QPCR on purified genomic DNA, homozygous, 
hemizygous and wildtype mice can be distinguished (Figure III.), and this assay was used 
to determine that this transgenic strain is homozygous lethal. RNA from these embryos 
was used to verify that homozygous embryos produce more DUF1220 RNA than 
hemizygous (Figure III.). In a series of timed pregnancies, the window of lethality was 





Figure III.15: QPCR Genotyping Assay 
This assay demonstrates the ability of a genotyping primer set, 
designed to recognize three DUF1220 domains, to detect wildtype, 
hemizygous and homozygous animals. DNA was extracted from embryos 
at approximately E12 from two different litters, arbitrarily labeled the “E” 
and “F” litters. A QPCR reaction using DUF1220 primers and primers 
designed to recognize endogenous mouse CFTR (a single copy gene) was 
run, and the ratio is shown here. Because human DNA (HXY2) contains no 
mouse CFTR, this sample appears as a 0 ratio (though raw values confirm 
detection of DUF1220). 
The brains of transgenic mice were evaluated for differences in cellular 
composition (Figure III.) using the isotropic fractionation method described by 
Herculano-Houzel and Lent (in collaboration with Suzana Herculano-Houzel and Mariana 
Gabi), by immunoreacting brain lysates with a NeuN antibody (which specifically labels 
neurons) and comparing the number of NeuN positive nuclei with the number of DAPI 




significant differences in numbers of neurons in any brain region examined (although a 
very slight reduction in total cell count in total cortex was found in hemizygous mice, 
and this difference met statistical significance; p = 0.0453, Figure III.18). 
Discussion. Here I describe an in vivo model to study the function of DUF1220. 
Specifically, a BAC containing human NBPF15 (which has 6 DUF1220 domains) was 




Figure III.16: More Genomic Copies of DUF1220 Produce More 
RNA 
RNA was extracted from mice genotyped as wild type (K3, K6 and 
K8), hemizygous (K10, K11 and K4) and homozygous (K5 and K7), reverse 
transcribed, and evaluated by digital droplet PCR for amount of DUF1220 
RNA product. Values from wild type animals are approximately 0, as 
expected, while values from hemizygous animals confirm RNA 
expression. The value from K5 is more than 4 times as high as any of the 
hemizygous animals, though K7 is 0. It should be noted that embryo K7 
may have been further in development than the other embryos in this 




Mice have one copy of PDE4DIP and no NBPF genes, yielding a total of 1 DUF1220 
domain. Interestingly, this suggests that mice may have evolutionarily lost these genes, 
as most other mammals have at least one NBPF gene ( O'Bleness, Dickens, et al. 2012). 
At the time of generation, these mice were suspected to have greater numbers of  
 
Figure III.17: Sample Litters Demonstrating the Window of 
Lethality 
Embryos collected from 5 separate litters arbitrarily labeled A - 
E are shown along with color coded genotype (red, wild type; yellow, 
hemizygous; green, homozygous). Note that younger litters, such as D 
(~ embryonic day (E) 10.5) and E (~ E11.5) still retain homozygous 
embryos, but older litters, such as B (~E15) and C (~E13.5) do not. 
Asterisks indicate uncertainty due to inconsistent genotypes. The “E” 






neurons in the neocortex based on the correlation between DUF1220 and cortical 
neuron number in anthropoid primates. No such difference in cortical neuron number 
was found in hemizygous mice, however. This result could be due to technical reasons, 
Figure III.18: Comparisons of Neural Architecture by Genotype 
6 male, wild type mice (blue) and their male, hemizygous litter 
mates (orange) were evaluated for cellular architecture  in the brain. No 
significant differences were found in neuronal density, non-neuronal 
density, total brain mass, or neuronal composition in the anterior cortex, 
posterior cortex, cerebellum or hippocampus. When total cell count was 
compared for all combined regions, a slight difference was observed, and 




such as the possibility that the BAC has not integrated in the manner that we suspect 
(based on the inability to sequence one of the two integration sites), or the possibility 
that there is a sex specific phenotype, as the mice evaluated for neuron number were all 
males. 
Since it is now known that DUF1220 may have another effect – specifically the 
down regulation of mitochondria in a cell density specific manner – it is alternatively 
possible that this result is consistent with observed DUF1220 function in vitro. Because 
brain size scales to body size at the same rate at which metabolism scales to body size in 
non primate mammals (as noted in section I), it is plausible that brain size is a 
metabolically driven feature of development. If the majority of the entire energy budget 
is dedicated to cell growth and division, and DUF1220 is limiting growth, it may 
effectively redirect the metabolic usage in a way that favors greater numbers of smaller 
cells, rather than fewer numbers of larger cells. In an animal with very small neurons at 
very high density, such as a mouse, one would not predict a large change in neuronal 
composition, as there is no metabolic surplus to be “redirected.” If the primary role of 
DUF1220 was to drive neural progenitor proliferation primarily without regard for cell 
size or cell density, significantly more neurons would be expected in transgenic mice. If 
DUF1220 is indeed generating more neurons by redistributing metabolic usage during 
neurogenesis, one would only expect a large effect in large brained animals. It is 
therefore conceivable that this explains not only the lack of effect in the mouse model, 




brained mammals listed in O’Blenness et al. 2012, as these genes are unnecessary 
among these animals. Further investigations of how DUF1220 influences cell size and 
cell density in cells derived from large brained, non primate mammals are necessary to 





SUMMARY, CONCLUSIONS AND FUTURE DIRECTIONS 
Summary 
DUF1220 domains. DUF1220 are a family of protein domains of unknown 
function, and have accrued the greatest gains in copy number of any protein coding 
sequence in the human genome. They exist primarily within the NBPF gene family, and 
regularly occur as tandem repeats of various length containing several domains within 
this family. A Ka/Ks analysis of DUF1220 domains has indicated that these domains are 
under heavy positive selection, indicating their expansion and expression are strongly 
favored evolutionarily (Popesco, et al. 2006). 
Copy number expansion of DUF1220 has occurred primarily within the simian 
primate lineages. Copy number of DUF1220 within these genomes strongly correlates to 
both brain size and neuron number. Within the human population, copy number gains 
of human chromosome 1q21.1, where most DUF1220 domains exist, have been linked 
to macrocephaly, while copy number losses have been linked to microcephaly (Brunetti-
Pierri, et al. 2008), and DUF1220 copy number in particular has been picked out of this 
region as the sequence most strongly associated with macrocephaly (Dumas, et al. 
2012). All of these data suggest that DUF1220 dosage may play a role in simian brain 




Neuron number by lineage. It has recently been discovered that the pattern of 
neuronal cell size and density in the brain varies substantially between mammalian 
lineages, making simple comparisons of brain size across lineages uninformative 
(Herculano-Houzel 2009). Instead, each lineage appears to have its own “rules” for 
describing these features. While most mammals appear to scale up the size of their 
neurons as their brains scale up through the lineage (thus decreasing density), primates 
are particularly unique in their scaling rules in that this does not occur. Neuronal cell size 
and density stays nearly constant across primates, such that a larger brain between one 
primate and another can be accounted for almost exclusively through added neurons. 
The power laws that describe the relationship between cortical mass (M) and cortical 
neuron number (N) approaches a squared function in rodents (M∝N1.744). Thus, as a 
cortex becomes larger in the rodent lineage, the number of neurons added become 
fewer. Alternatively, the power law that describes the primate relationship between 
cortical mass and cortical neuron number are nearly linear for primates (M∝ N1.077). A 
larger brain in this lineage can therefore be accounted for almost exclusively by added 
neurons. This highlights the dramatic difference in neuron number experienced by each 
lineage with increasing brain size. The mechanisms that govern the scaling rules in 
rodents and primates are currently unknown. 
Work presented here. Using in situ hybridization analysis of formalin fixed, 
paraffin embedded human fetal brain tissue, I have shown here that DUF1220 domains 




not at any other point in development. This spatiotemporal window corresponds most 
likely to cells destined to become primary excitatory neurons of the superficial layers. 
This expression pattern, when considered with the correlation between DUF1220 copy 
number and primate brain expansion, suggests that at least one function of DUF1220 
domains may be to promote proliferation of the neural progenitor cells found in this 
part of the embryo at this time. 
In order to investigate this possibility, non-cancerous, human neural stem cells 
cultured in minimal media were transfected with either NBPF15 – a gene with 6 
DUF1220 domains – or a mock construct, and evaluated for confluency at regular time 
points. NBPF15 transfected cells consistently show a rapid burst of proliferation that 
levels off after approximately 90 hours, while mock transfected cells show an immediate 
reduction in confluency and tend to maintain approximately the same level of 
confluency. 
RNAseq was used to investigate the pathway in which DUF1220 domains 
function. Rather than the previously described human neural stem cells, a DLD1 line was 
used as a background cell line. DLD1 cells are an adenocarcinoma cell line with very low 
DUF1220 expression. Because of this, the effect of over expressing DUF1220 on DLD1 
cells is more readily apparent than when over expressing in neurons, in which 
downstream biological processes may already be active, making DUF1220-initiated 
changes more difficult to detect by RNAseq. Two doxycycline inducible, stable lines were 




7 DUF1220 domains), called DLD1Tr21/NBPF1 and the other a mock, called 
DLD1Tr21/Mock. mRNA was collected from both doxycycline treated and untreated 
cells for both cell lines, and these were evaluated for changes in the transcriptome. 
Many genes involved in mitochondrial function were found to be significantly 
down regulated in the DLD1Tr21/NBPF1 cells over expressing NBPF1, while no clearly 
discernible pattern was detected among genes up regulated. The mock cell line did not 
show a drop in expression of mitochondrial related genes, and also showed no pattern 
in neither up nor down regulated genes. Though the down regulation of mitochondria 
related genes in the NBPF1 over expressing cells was significant, the result was strongly 
driven by one replicate in particular. (Quantification of GFP did not indicate that this 
sample was expressing the transgene any more strongly than any of the other samples – 
data not shown.) 
These cells were then cultured in the presence of MitoTracker, a fluorescent dye 
that accumulates in active mitochondria and fluoresces. Fluorescent images of the cells 
were captured at regular intervals, and the fluorescence intensity was then compared. 
DLD1Tr21/NBPF1 cells induced to over express NBPF1 showed substantial repression of 
MitoTracker signal, supporting the RNAseq results. 
In order to investigate the potential effect on mitochondrial function, 
DLD1Tr21/NBPF1 and DLD1Tr21/Mock cells were analyzed on a Seahorse XF24, which 
measures the oxygen consumption rate of cells and the extracellular acidification rate in 




but significant reduction in their rate of ATP turnover and in their baseline respiration. A 
similar trend was observed in mock cells, but this trend was not significant. Though not 
significant, a slight reduction in proton leak (thought to regulate body heat) was also 
observed in cells induced to over express NBPF1. 
Because the Seahorse has specific cell density requirements that are slightly 
lower than those used in the MitoTracker experiment, and because RNAseq results were 
strongly driven by one sample, it is possible that the DUF1220 domains exhibit a cell 
density specific effect. A MitoTracker experiment was performed with high, medium 
and low cell density. At medium and low cell densities, the suppression of MitoTracker 
signal was not observed. 
Conclusions 
 A connection between DUF1220 and primate-specific neuronal scaling. The 
interesting trend in neuronal scaling (very prominently in the cerebral cortex) that 
appears to be unique to primates could very likely explain the apparent differences 
observed between primates and non primates of similar brain size (Herculano-Houzel 
2009). It is also plausible that the pronounced increase in neuron number may underlie 
the cognitive abilities of the human brain.  Although neuronal scaling rules have not yet 
been described for larger brained animals, such as pachyderms and cetaceans, it is 
conceivable that this trend applies to these lineages as well, and may therefore explain 
the observation that humans do not possess the largest brains found in nature, but 




neuronal scaling rules that describe the pachyderm lineage are similar to those 
describing the rodent lineage, then an elephant brain – which can be approximately 2-3x 
larger than a human brain – would be expected to have substantially fewer neurons 
than a human brain. 
 That DUF1220 domains have preferentially expanded in copy number in the 
primate lineage suggests a possible causal relationship between this expansion and the 
primate specific neuronal scaling rules. The scaling rules in primates seem to imply at 
least two critical components. The first is a mechanism to limit cell size, and therefore 
disconnect it from organ (or body) size. The second is an enhanced proliferation, such 
that an increase in brain size is accounted for primarily by cell number. Because 
DUF1220 domains have demonstrated an ability to both drive neural progenitor 
proliferation and to suppress mitochondria, they make reasonable candidates to be 
driving both of these biological functions. 
Models. Evidence in this thesis suggests two roles for DUF1220 domains: 1) 
stimulation of neural progenitor proliferation and 2) suppression of mitochondrial 
output in a cell density specific manner. Though these two functions seem intuitively 
unrelated (or perhaps even opposed to one another), it may be true that one of these 
two functions is the primary function of DUF1220 domains, while the other is a 
secondary association. The models presented here are therefore arranged in a way that 




Models in which neural progenitor proliferation is the primary effect of DUF1220 
domains: a centrosomal effect.The ancestral DUF1220 domain exists near the C-terminal 
end of a large gene, phosphodiesterase family member 4D interacting protein 
(PDE4DIP). Like its ortholog, CDK5RAP2, PDE4DIP is expressed at the centrosome (Verde, 
Pahlke, et al. 2001). CDK5RAP2 is one of at least 7 MCPH genes (Thornton and Woods 
2009) – genes implicated in the pathology of autosomal recessive primary microcephaly. 
The drosophila ortholog of CDK5RAP2, centrosomin, is known to interact with the γ-
tubulin ring complexes, where the microtubules for the mitotic spindle are created. 
Mutations in centrosomin cause a reduction in cell number, both in the central and 
peripheral nervous systems (Li and Kaufman 1996). CDK5RAP2 may therefore be 
affecting the availability of microtubules required to build the spindle (Cox, et al. 2006), 
or may otherwise affect the orientation of the centrosome during neural progenitor 
proliferation. Similarly, PDE4DIP is predicted to contain a γ-tubulin binding domain near 
its N-terminus (based on Pfam prediction), and may therefore be functioning in a similar 
manner. 
In mice, the earliest progenitor cells (neuroepithelial cells) have an attachment 
to the apical surface. Early divisions bisect this attachement such that each daughter cell 
receives apical attachment proteins, remains attached to the apical surface, and 
(possibly because of this attachment) retains the neuroepithelial identity. This division is 
called a symmetrical proliferative division. Later in development, asymmetric divisions 




attached will migrate basally and become either a basal progenitor or a neuron. The 
number of rounds of symmetric cell divisions that occur before cell begin to divide 
asymmetrically is therefore a determinant in the final number of neurons. It has been 
pointed out that 10 rounds of asymmetric cell division by one progenitor would produce 
10 neurons. If all but the last round of cell division are symmetric, however, one 
progenitor will produce 512 neurons (Thornton and Woods 2009). The type of cell 
division (symmetric vs. asymmetric) is thought to be controlled by the orientation of the 
centrosomes within the cell. The association between DUF1220 and brain size therefore 
suggests that the PDE4DIP, which is expressed at the centrosome and contains a 
DUF1220 domain, may play a role in this orientation. 
Models in which neural progenitor proliferation is the primary effect of DUF1220 
domains: primary cilia as a balance between proliferation and cell density-dependent 
differentiation. Primary cilia are sensory structures long thought to be the balance 
between further progression through the cell cycle and cell cycle exit. An effect on this 
structure might therefore be an ideal place to both sense local cell density and drive 
additional rounds of proliferation. 
Vandepoele et al. showed that NBPF1 protein, which has 7 DUF1220 domains, 
directly interacts with a protein called chibby (Vandepoele, Staes, et al. 2010). Chibby is 
known to be involved in two cellular processes. The first is as a negative regulator of the 
Wnt/beta catenin pathway, wherein chibby is capable of migrating into the nucleus, 




catenin-mediated transcription from occurring (Takemaru, et al. 2003; Li, et al. 2008). 
The second function ascribed to chibby occurs at the centriole, where it acts as a 
scaffold upon which the primary cilium is built. When Vadepoele et al. performed a 
TOPFLASH assay to investigate whether addition of NBPF1 had any effect on Wnt/beta 
catenin signaling in DLD1 cells in culture, they found no change between NBPF1 and 
mock induced cells. It is therefore possible that the nature of the NBPF1/chibby 
interaction is to influence primary cilia generation, which could affect the cell cycle. This 
would be consistent with the discovery that many NBPF genes have duplicated the 
promoter from an unrelated, centrosomal gene, EVI5 (Vandepoele, Andries and van Roy 
2009). 
Primary cilia are well conserved structures, present in every organ of the human 
body (Anderson, et al. 2008). They are non-motile, sensory organelles, built during G1 of 
the cell cycle and mark the exit from the cell cycle, into G0. Conversely, resorption of the 
primary cilia is associated with reentry into the cell cycle. This is thought to be true 
because the centrioles nucleate both the primary cilium and the centrosome, which is 
necessary for mitosis (Plotnikova, Pugacheva and Golemis 2009). In this model, the 
centriole therefore functions as a fulcrum upon which exit from the cell cycle is 
determined. 
Chibby is known to localize to the distal end of the mother centriole, upon which 
a primary cilium is built, and it is essential for primary cilium construction (Steere, et al. 




as a structural support during primary cilia generation would prevent the cell from 
exiting the cell cycle, and therefore force extra rounds of cell division. 
Circumstantial support can be found in many ependymomas, which are tumors 
of the ependymal cells that line the ventricles of the brain in adults (the cells that radial 
glia ultimately differentiate into). Interestingly, the two most common genetic 
aberrations found in these diseases are a gain of chromosome 1q (where most of the 
DUF1220 domains map) (Mendrzyk, et al. 2006) or a loss chibby (Karakoula, et al. 2008). 
Because the primary cilium is known to localize many receptors, it is likely that 
this structure is sensing cell density (Plotnikova, Pugacheva and Golemis 2009). This may 
therefore be the manner in which cells switch from proliferation to differentiation. At 
lower cell densities, DUF1220 may bind to chibby and inhibit cell cycle exit. When some 
threshold is reached, a receptor dependent signal – possibly a dosage dependent signal 
– may shift chibby into a ciliary role (possibly by competitive binding), and free up 
DUF1220 to inhibit mitochondrial output. Though highly speculative, it is plausible that a 
system of increased proliferation would require a mechanism to temporarily stop cell 
cycle exit and differentiation, but also require a mechanism by which it can be turned 
off itself. 
Models in which suppression of mitochondria is the primary effect of DUF1220 
domains. Rather than driving neural progenitor proliferation, DUF1220 may be primarily 
acting to suppress mitochondrial output at specific cell densities, and the proliferation 




as suggested by V. Andries, personal communication). The fact that no other lineage 
observed thus far has shown a relationship of cortical mass to cortical neuron number 
as close to linear as primates suggests that most species are not actively affecting cell 
density, but are instead passively drawing as much energy as possible during cell 
proliferation, such that larger animals tend to have larger cells. That cell density is more 
consistent throughout the primate lineage, however, suggests that primates are actively 
adjusting this feature. If the entire energy budget available to a fetus goes toward 
growth and division during the proliferative phase of fetal brain development, then 
simply by keeping cell size small (and therefore cell density constant), DUF1220 domains 
save the fetus a tremendous amount of energy that would otherwise go to generating 
larger cells. More cells may therefore be generated passively by virtue of the fact that 
the full energy budget goes towards growth and division during this phase, but growth is 
actively being limited. This may explain why the transgenic mouse model described here 
did not exhibit additional neurons: if the primary effect of DUF1220 is to keep cell size 
down in an animal that is already optimized to have very small cells, there may be no 
observable difference. The cells in this animal will stop growing before the effects of 
DUF1220 would be observed. In a species with a sufficiently large enough brain, 
alternatively, one would expect a substantial shift in cell size and cell density, which may 





Models in which suppression of mitochondria is the primary effect of DUF1220 
domains: neoteny. Heterochrony is any difference between a species and its ancestral 
form in the timing or duration of developmental events, such as neural progenitor 
proliferation. Neoteny occurs when the developmental window in the extant species is 
lengthened. In the absence of available data regarding rates of development in ancestral 
forms, extant species are frequently used instead. Indeed, it has been observed that the 
window of brain development has been extended from mouse to macaque, and from 
macaque to human Kornack and Rakic 1998, and this pattern is thought to extend to 
many other primate species (Finlay and Darlington 1995; Clancy, et al. n.d.). In a primate 
model of brain development that emphasizes neuron number per unit time, rather than 
accumulation of cell mass, such a protracted window of neural development makes 
intuitive sense: more time spent in this stage may generate more neurons, and thus a 
bigger brain. Drawing out the window of development during which neural progenitor 
cells are generated, therefore, is a plausible mechanism by which DUF1220 may be 
influencing neural development. 
A second, less obvious possibility is that the extra time humans spend in the 
window of neural development preserves the long distance connectivity important for 
social intelligence, and changes in this timing may underlie certain cognitive diseases. 
The human brain develops in an “inside out” pattern, with each wave of dividing 
neurons migrating past their predecessors and taking up residence basally to those cells.  




the cortical plate and project its neurites outward. If cell division occurs too quickly and 
the next wave of dividing neurons is immediately behind the former, the developing 
cortex will get crowded very quickly. These cells will most likely not have enough time to 
send out neurites before being physically blocked by the next wave of neurons settling 
on top of them – particularly long distance projection axons.  This inability to form long 
distance projection neurons may therefore lead to the overly localized connectivity 
pattern seen in autism (Courchesne, et al. 2007).  The combination of not only how 
many neurons are made, but also how fast they are made, may therefore explain why 
greater than average brain growth is associated with autism in some people and not in 
others, and offers a potential explanation of why DUF1220 can be associated with both 
macrocephaly and autism (Dumas, et al. 2012; Davis et al., submitted). 
As described, DUF1220 domains can promote proliferation in neural progenitor 
cells in culture, suggesting that something else may be responsible for the delay in 
development. Because there are different clades of DUF1220 domains, however, it is 
also possible that these clades take on complimentary roles. For example, an association 
between CON1 dosage and the severity of classic autism symptoms has been described 
(Davis et al., submitted), but no such association has been made for other clades.  If 
CON1-type DUF1220 domains are promoting cell proliferation in neural stem cells, and 
HLS-type DUF1220 domains are slowing the rate of division, then a genomic 
rearrangement in an individual leading to a balanced increase in both types of domains 




copy number occurs such that more CON1-type DUF1220 domains are present and 
driving neural proliferation without a concomitant increase in HLS-type DUF1220 
domains to control the rate of cell division, the extra neurons produced may not have 
enough time to establish normal connectivity, instead taking on the hyper localized 
connectivity observed in autistic individuals. 
Future Directions 
Future work should build off of these results and expand our knowledge of the 
biological role(s) of DUF1220. Specifically, a major effort to investigate the models 
presented here may help inform our understanding of the biology underlying human 
brain expansion, and this knowledge could be useful in understanding the cognitive 
diseases that can manifest when variations to this system occur. Specifically, efforts to 
investigate the possibility that DUF1220 is primarily driving either neural progenitor 
proliferation or mitochondrial down regulation are particularly useful. Ideally, this would 
be tested in a new transgenic species with larger brains. Because it is not feasible to 
generate transgenic horses or cows, it is instead useful to compare cell sizes and division 
rates in vitro. Mouse and bovine cells can be investigated for proliferation rates and 
differences in cell sizes in a culture system. 
These cell culture models and the human neural progenitor model presented in 
Figure III.6b can be grown with varying amounts of DUF1220 expression and varying 
amounts of serum in the culture medium. By growing cells in serially increasing amounts 




transfected, it may help elucidate whether the proliferation effect is dependent upon 
the amount of energy available to the cells. If DUF1220 is primarily driving proliferation, 
then one expects a proliferatory effect in all three cell lines, the rate and duration of 
which is dependent only upon the number of DUF1220 domains transfected. 
Specifically, one expects a positive (likely linear2) relationship of DUF1220 copy number 
to neuron number in culture, and that this trend is independent of serum in media, 
because the effect of DUF1220 on cell proliferation is primary. If the mitochondrial 
down regulation previously described is a secondary association, then the cell density of 
each lineage should reflect the species from which it came and not be modified by the 
addition of DUF1220 domains. 
Alternatively, if human and bovine cells but not mouse cells exhibit exaggerated 
proliferation, and the proliferation effect (relationship of DUF1220 copy number to 
neuron number) is dependent upon the amount of serum in the medium, it supports the 
idea that DUF1220 is primarily acting to limit cell size, thus freeing up available energy 
and effectively stretching resources. In this case, the proliferation effect is secondary 
because the cells are essentially making use of “leftover” resources.  
In the event that DUF1220 is actively driving both proliferation and cell density, 
one would expect to see a relationship between DUF1220 copy number and neuron 
                                                     
2 The selective pressure driving copy number expansion argues that some type of 
dosage sensitive relationship exists, and that this relationship will be a positive value 




number that is independent of serum amount, as in the first scenario, but would also 
expect cell densities from all three species to align to very similar values. In addition to 
further examining the role of DUF1220 in down regulating mitochondria and driving 
neural progenitor proliferation, this experiment will also neatly address the question of 
what role DUF1220 copy number plays in this process. 
Although the DLD1Tr21/NBPF1 system has provided us with a remarkable 
system in which to test the effects of DUF1220 over expression, the results should be 
interpreted with caution, as these are cancerous, and do not come from a neuronal 
lineage. It would be very informative to investigate the effect on human neural 
precursors in culture. Rather than testing the effect of NBPF1, future work should focus 
on individual DUF1220 clades independently, and in conjunction with one another. 
RNAseq analysis of each clade of DUF1220 at various cell densities in normal, human 
neurons has the potential to inform us as to whether these domains take on separate 
and complimentary roles, or are simply variations of the same function, and must 
therefore work in conjunction with other proteins in order to affect primate neuronal 
scaling.  
Human neural stem cells in culture have provided us with a very powerful 
system in which to investigate DUF1220 biological activity. Still, this system is artificial in 
that the cells have been removed from a heterogeneous population of cells growing in a 
three dimensional environment. In an effort to recapitulate an in vivo system as closely 




three dimensional gel matrix. This system will not only help us provide a more true to 
life architecture, but has the potential for investigation of DUF1220-dependent 
differences in lateral expansion, as predicted by the centrosomal model. 
Although primates – and especially humans – are more desirable to study the 
biological role of DUF1220 because of the preferential copy number expansion that has 
occurred in this lineage, these studies are limited primarily to cell culture experiments. 
There are potential limitations to these types of experiments, as they remove cells from 
their normal developmental environment and attempt to mimic this environment, 
though many components of the natural environment are still unknown. A deeper 
understanding of the biological role of DUF1220 domains might be facilitated by the use 
of transgenic animals. While we have already developed mouse models and work is 
currently underway to evaluate these mice for neuroanatomical and behavioral 
changes, we are aware that mice have only one occurrence of DUF1220 in their 
genome, and this is the ancestral form that occurs in PDE4DIP. It is possible that the 
results of these studies may be limited in the event that mice do not possess the cellular 
components required to respond to exogenous DUF1220. Model systems that start with 
a slightly higher DUF1220 content (of a clade more similar to the primate clades, rather 
than the ancestral PDE4DIP clade), such as rabbits, may therefore complement these 
studies. 
Because multiple clades of DUF1220 exist, it is possible that they have 




each bearing a unique DUF1220 clade member could be generated. These could be used 
to treat H9 derived neuronal progenitor cells in culture, which could then be evaluated 
for proliferation by live cell imaging or transcriptomics by RNAseq. Further, NBPF genes 
have two distinct promoters, a CM promoter and an EVI5 promoter (O'Bleness, et al. 
2012). Reporter constructs that contain a CM, EVI5 or both promoters could be 
compared for signal intensity through each stage of the cell cycle for spatiotemporal 
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